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CHAPTER 1: AUTOPHAGY IS UPREGULATED IN A DROSOPHILA FRDA MODEL AND
ASSOCIATED WITH APOPTOSIS AND MITOPHAGY
1. Introduction
1.1

Friedreich’s ataxia: features and genetics
Friedreich’s ataxia (FRDA) is the most prevalent inherited recessive ataxia, affecting about

1 in 40,000-50,000 individual in the United States and Europe (4). It mostly affects Caucasians, as
well as North Africans and Middle Easterners, without gender differences (5). The onset of FRDA
is usually around puberty, but the range may vary from 2 years old to the late 30s (5). FRDA
progressively affects the central nervous system (CNS) and peripheral nervous system (PNS), as
well as the heart and skeletal muscles. The symptoms include muscle weakness in the arms and
legs, heart disorders, loss of coordination, vision and hearing loss, dysarthria, scoliosis, and
diabetes (6). Unfortunately, currently there is no treatment for FRDA. Recent studies show that
the addition of the control Frataxin gene could rescue the Frataxin mutation cells in yeast, mice,
and humans (7-9). However, the amount of Frataxin expression should be carefully monitored
because over-expression up to 8-to-10 fold has deleterious effects in the Drosophila model (10).
The above research indicates that more detailed information is required for effective treatment
of FRDA.
In 1996, Campuzano and colleagues found that FRDA is caused by expansion of GAA
triplets at chromosome 9q13-9q21.1 region, which contains candidate gene X25 (11). They
further clarified that the disease is caused by a deficiency of an 18kDa mitochondrial membrane
protein encoded by X25, which they named Frataxin (FXN) (12). The human FXN gene has 7
exons and extends for 95 kb on the genome (11). Frataxin protein is associated with the
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mitochondrial inner membrane and crests. It is highly conserved from bacteria to plants and
mammals (13, 14). The nuclear-encoded FXN gene is transcribed through the first five exons to
produce a 210 AA (23 kDa) precursor protein isoform with N-terminal mitochondria targeting
sequence. The precursor is then transported into the mitochondria and enzymatically cleaved
between Gly41 and Leu42 to form a 169 AA intermediate m42-FXN (intermediate-FXN,
corresponding to residues 42-210) by mitochondrial processing peptidases (MPPs) (15). The 19
kDa intermediate then undergoes further cleavage by MPPs to produce the mature form of
Frataxin protein (16). There are three mature different Frataxin protein isoforms reported, m56FXN, m78-FXN, and m81-FXN. Cavadini and colleagues first described a 155 AA, 17 kDa m56-FXN
as a matured and functional form of Frataxin in humans in 2000 (16). In 2007, Condo and Testi
published their finding of a 130AA, 14.2 kDa m81-FXN as the major form of Frataxin protein in
human cells, such as human heart and peripheral blood lymphocytes and dermal fibroblasts (17).
Another isoform was discovered by Yoon et al. in 2007, which is cleaved at site 78 to form a
133AA, 14.5 kDa m78-FXN (18). Currently, it is still not clear about the major form of matured
Frataxin in vivo. Some explanations were proposed that different isoforms may be the result of
different physiological conditions. For example, Gakh and colleagues found that both m42 and
m81-FXN were present in normal cells under steady-state conditions, but m42-FXN seems to be
degraded faster than m81-FXN in FRDA patients. Besides that, the m42 and m81-FXN also differ
in the ability of oligomerization and iron/iron-sulfur cluster delivery which will be discussed later
(19).
It is now established that the large expansion of trinucleotide repeats GAATTC within the
first intron of the Frataxin gene occurs in most clinical cases of FRDA. Around 98% of FRDA
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patients are homozygous for the GAA expansions, while the rest carry one expansion allele and
one point mutation in the other allele (11). The length of the GAA repeat expansion in the
smaller allele is positively correlated to disease progression and negatively correlated with the
age of onset (20, 21). The repeats expansion ranges from 43 to more than 1700, compared to
the 8-42 in unaffected people. Long repeats significantly reduce the level of Frataxin mRNA up to
70% (11, 21).
Multiple hypotheses have been proposed to explain how the increment of GAA repeats
reduces the level of Frataxin mRNA. One of the major hypotheses suggests that when
transcribed, the GAA repeats produced a corresponding mRNA segment that could bind to the
DNA template forming DNA triplexes or DNA: RNA hybrid structures (22, 23). According to
Grabczyk’s work, which was done in vitro with T7 RNA polymerase, the DNA: RNA hybrid
structure forms during the transcription of the long repeats and arrests the RNA polymerase at
the GAA.TTC region, thus reducing the level of Frataxin mRNA (22). The DNA triplex, through
interactions with two neighboring long repeated regions, forms a GAA.GAA.TTC structure
(termed sticky DNA). This “sticky DNA” not only reduces the transcriptional efficiency but also
affects the genetic stability of the DNA locus containing the trinucleotide repeat (23).
On the other hand, some researchers have shown that increasing the number of GAA
repeats within the first intron of Frataxin does not affect pre-mRNA process, but rather the
splicing efficiency of the first intron during the maturation (24). One new hypothesis comes from
Saveliev’s work, which proposes that long repetitive repeats tend to trigger the
heterochromatin-like effect on the genome, thus repressing gene transcription (25). But until
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today, the connection between the length of the triplet repeat and Frataxin mRNA and protein
reduction is still under debate.
The Frataxin was expressed in all tissues, but it is enriched in heart, brown fat, kidney,
liver, and certain neurons, most of which are highly metabolic and mitochondria-enriched tissues
(14, 26). Therefore, as expected, the deficiency of Frataxin in FRDA patients usually causes
more significant damage to those mitochondria-enriched tissues than in the other organs. The
importance of Frataxin for survival varies among species. Simple unicellular organisms such as
yeast can survive without Frataxin, but the complete absence of Frataxin is lethal for all studied
multi-cellular organisms such as mammals (27). Multiple reviews have been published on the
pathology of nervous system dysfunction in FRDA in humans and animal models (5, 28-30). The
neuronal system is usually the first to be affected. The early onset FRDA patients commonly
show declining motor skills as the first symptoms of the disease (30). Most of the FRDA patients
ultimately suffer from cerebellar and brain stem atrophy, as well as lesions of cerebral white
matter (31). The FRDA patients show a reduction in spinal cord diameter up to 30% compared to
control cases, especially in the thoracic region, indicating fiber loss, such as gracile and cuneate
fasciculi (32). The magnetic resonance imaging (MRI) results also revealed more than 60% loss in
superior cerebellar peduncle (SCP) volume in FRDA cases (33). Dentate nuclei (DN) atrophy,
accompanied by the degeneration of gray matter, occurs in most cases and becomes a
biomarker for the diagnosis of FRDA (28, 34).
Currently, the most accepted hypothesis is that Frataxin is involved in iron metabolism in
the mitochondria (27). The deficiency of Frataxin usually results in the abnormal accumulation of
iron deposits in the mitochondria, and this apparently causes multiple enzyme deficits,
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mitochondrial dysfunction, and oxidative damage. Eventually, this leads to neuron degeneration
and a shortened lifespan (35). The deposit of iron in myocardial cells of three FRDA cases were
first confirmed by Lamarche et al. in 1980 (36). Based on structural analyzes, Frataxin is possibly
required for the assembly of iron-sulfur clusters (ISC). The negatively charged amino acids on the
Frataxin surface could bind ferrous iron and promote the mitochondrial synthesis of ISC by
controlling the ability of iron to participate in redox reactions (37). The detailed role of Frataxin
in the ISCs is also being extensively studied. The ISC are involved in a series of important
processes such as electron transport, energy metabolism, DNA repair and iron handling (38).
The cluster consists of a group of proteins, including two molecules of IscS (Nfs1 in mammals)
and two molecules of IscU to form the scaffolds of the complex (37). It is still debatable if the
Frataxin protein directly binds to the IscU proteins.
1.2.1

ROS and Autophagy in FRDA

Reactive Oxidative Species (ROS) refers to a group of highly reactive, oxygen-containing
chemicals such as hydroxyl radical (•OH), hydrogen peroxide (H2O2), and superoxide radical (O2•). Under physiological conditions, ROS molecules such as O2•− were produced in the
mitochondrial matrix by Complex I and III and quickly removed by matrix manganese superoxide
dismutase (MnSOD) (39). Because the O2•− produced in the matrix cannot cross the membrane
unless it is protonated, the O2•− accumulates in the mitochondrial matrix. ROS, especially •OH
that is produced by Fe(II) and H2O2 through the Fenton reaction, attack and oxidize the lipid, DNA
and protein molecules inside the cell, causing cellular structural changes that are often
associated with diseases.

6
The connection between Frataxin deficiency and ROS damage was first discovered in
yeast. The Frataxin deficiency yeast strains ΔYFH1 and YDL120 were hypersensitive to oxidative
stress (40, 41). This was confirmed by Wong et al. in 1999 in mouse models when they observed
that mouse FRDA fibroblasts show hypersensitivity to iron stress and hydrogen peroxide,
suggesting the significant impact of ROS to disease progression (42). Amoros and colleagues
reported that in SH-SY5Y human neuroblastoma cells with reduced Frataxin level have an
increase in oxidative stress markers such as superoxide radical anion production and protein
carbonylation, suggesting that there is an upsurge in oxidative stress upon Frataxin deficiency
(43). Another piece of direct evidence for increased ROS production in Frataxin deficiency was
attributed by measuring the level of O2•− in FRDA-mutant mouse lymphoblasts using the
dihydroethidium (DHE) method, which is a dye that localizes to mitochondria with a normal
electron density gradient. It showed that there is an increase in ROS in FRDA-deficient cells about
80% compared to control cells(44).
There are several theories being developed on the effect of ROS in FRDA model
organisms (45-47). One of the major hypothesis is that the increased ROS cause damages by
interfering with the essential Fe-S cluster synthesis associated with Frataxin. The integrity of Fe-S
clusters in the mitochondrial respiratory complex enzymes must be well maintained to prevent
the failure of electron transfer. It allowed the electron leakage to be kept at the minimal level to
avoid the production of ROS (48). The O2•− in FRDA-mutant E. coli inactivated prosthetic Fe-S
cluster-containing enzymes through an oxidative attack (39). The research by Anderson et al.
showed that ectopic expression of H2O2 scavenging enzymes, such as catalase (CAT) and SOD1,
could partially rescue the short lifespan phenotype in Frataxin-deficient Drosophila (49).
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The sensitivity of FRDA-deficient yeast cells to H2O2 was associated with an increase in
the activated form of Caspase 3, a possible link to increased apoptosis (50). Second, it was
proposed that the ROS-related damage in FRDA-deficient mouse cells includes mitochondrial
DNA damage and nuclear DNA loss (51, 52). The work from Karthikeyan et al. confirmed that
Frataxin-deficient yeast showed higher DNA damage reporter signals accompanied by increased
ROS levels(53). Under normal conditions, superoxides are produced in the mitochondrial matrix
and removed by superoxide dismutase (SODs) (54). The SODs, which belong to the Phase II
detoxification pathways, were controlled by Nrf2 (nuclear factor-erythroid 2-related factor 2).
Nrf2 is a cytosolic protein sequestered by Keap1 protein, and its activity is repressed at basal
levels (3). Once the oxidative stress increases, the Keap1 protein is modified through oxidation,
which releases Nrf2 into the nucleus. Nrf2 is phosphorylated by protein kinase C (PKC) at Ala 40
and tethered with a small protein heterodimer MafG binds to antioxidant responsive elements
(ARE) DNA sequences. The binding in turn activates the transcription of Phase II antioxidant
genes, such as SODs, glutathione, glutathione reductase, and glutathione-S-transferase (GST) to
counteract the stress (55-57).
The defects of antioxidant mechanisms, including the reductions of SODs and
glutathione, were also reported in FRDA cases. The SOD levels were only moderately upregulated, and its upstream Nrf2 signaling pathways were defective in FRDA cells. Data showed
that in cultured human FRDA fibroblasts, Nrf2 failed to associate with the clustered, phalloidinreactive filamentous structure, termed actin stress fibers, to translocate into nucleus (58). As a
result, the antioxidant enzymes such as catalase, GSTP1, NQO1, and SOD2 all showed
significantly reduced induction under oligomycin or tert-Butylhydroquinone(tBHQ) treatment,
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indicating a dysregulation of Nrf2 signaling during oxidative stress (58). In FRDA yeast, the total
glutathione level was reduced to 20% compared to control samples, as well as glutathione
peroxidase activity (59).
There are studies published about the beneficial effects of antioxidant supplement
methods, including ectopic expression of SODs and increasing glutathione levels. For example,
some studies of FRDA drug therapies have investigated the use of idebenone, which is a
synthetic short-chain benzoquinone similar to the mitochondrial antioxidant coenzyme Q10(60).
Idebenone is capable of reducing the membrane damage and protecting mitochondrial function
as an electron carrier in FRDA cells. Research has shown that idebenone is beneficial for reducing
the neurological dysfunction in the Drosophila FRDA model. However, clinical trials of idebenone
failed to provide significant therapeutic benefits in FRDA patients (61-64). These results indicate
that the oxidative-stress reducing pathways through SODs are partially affected in FRDA patients.
However, the anti-oxidative stress mechanisms in FRDA are affected by multiple factors and
need further clarification.
Besides antioxidant enzymes, autophagy is another major defensive mechanisms against
ROS by removing oxidative-stress damaged cytosolic contents, especially long-lived and
aggregated proteins and damaged organelles (65). Briefly, a double-membrane vesicle called the
autophagosome extends and encompasses cytosolic components, such as defective
mitochondria or large protein aggregates. The autophagosomes then fuse with the lysosomes or
endosomes where the contents are degraded and subsequently recycled (65). Autophagy
dysfunction has been linked to several diseases, including systemic lupus erythematosus, Danon
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Disease, Parkinson’s diseases, and cancers (66-70). But the description of autophagy in FRDA is
limited.
The autophagy pathway includes initiation, nucleation, elongation, fusion and the final
degradation steps, which require over 31 autophagy-related (Atg) genes (71). The protein mTOR,
which is short for the mammalian target of rapamycin, is the major sensor of cellular nutrition
deprivation and controls the initiation of the autophagy pathway. Autophagy starts with the
initiation of a double-membrane structure called the phagophores, which form after stress
signals such as starvation, hypoxia, or oxidative stress. The phagophores associate with other
proteins such as RAPTOR (Regulatory Associated Protein of mTOR), DEPTOR (DEP-domain containing
mTOR interacting protein), MLST8 (mammalian lethal with Sec-13 protein 8, also termed GβL (G

protein beta subunit-like)), and PRAS40 (proline-rich Akt substrate of 40 kDa) to form mTOR
complex 1 (mTORC1), which suppresses the activity of the Atg1 complex. The induction process
requires the suppression of mTORC1 and activation of the Atg1 complex. The Atg1 complex in
yeast contains Atg1-Atg13-Atg17, and the complex in Drosophila possesses Atg1, Atg13, and
RB1CC1(72, 73). In mammalian cells, Ulk1 (unc-51 like autophagy activating kinase 1), which is
the mammalian Atg1 homolog, Atg13, and RB1CC1 are constitutively bound. But under normal
conditions, mTOR inhibit the Atg1/Ulk1 complex by hyper-phosphorylating Atg1/Ulk1 and Atg13
(74, 75).
During starvation or other stress signals, mTOR is inactivated. Ulk1 and Atg13 are
dephosphorylated and activated. The dephosphorylation of Ulk1 activates its kinase activity,
which phosphorylates FIP200(FAK-family interacting protein of 200 kDa, mammalian Atg17
homologue) to form the Ulk1-Atg13-RB1CC1-FIP200 complex and translocate to the isolation
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membrane, termed pre-autophagosome or phagophore (75). It is suggested that the binding of
Atg13 increases Atg1 stability (76). Currently, the origin of the double membrane is not entirely
understood. It is suggested that the source of raw materials to build the phagophores may be
the rough endoplasmic reticulum (rER), Golgi or mitochondria (77). It is found that Atg9 may
contribute to induction by collecting and chaperoning the membrane components from an
unknown cytosolic pool to the phagophore assembly site (PAS) (78). The structure characteristic
of autophagy, the double membrane phagophore, accumulates in the PAS and enters the next
step of expansion.
Current studies reveal that the expansion of the phagophore is controlled by
phosphatidylethanolamine (PE) conjugated Atg8b, which is catalyzed by two ubiquitin-like (UBL)
systems. The first UBL system is the direct binding of Atg8a to the pre-autophagosome
membrane (79). Shortly after the synthesis of Atg8a protein or its mammalian ortholog LC3-I
(microtubule-associated protein 1 (MAP1) light chain 3 form I), Atg8a/LC3-I is cleaved by Atg4 to
reveal a C-terminal glycine residue and Atg8a/LC3-I then resides in the cytosol (79). Atg8a/LC3-I
next conjugates to the PE to produce Atg8b/LC3-II. Atg8b/LC3-II incorporates into the
autophagosome membrane and remains attached until the autophagosome is degraded by the
lysosome when the two organelles fuse at the end of the autophagosome cycle.
Atg8b/LC3-II is a widely used marker for autophagy quantification (80). The second UBL
system is the formation of Atg12-Atg5-Atg16 complex, which is independent of Atg8a/b (81).
After the activation by Atg 7, Atg12 is then covalently bound to Atg5 through a series of
ubiquitin-like conjugation reactions. Atg16 is also necessary for the membrane biogenesis (82).
The Atg12- Atg5 conjugate interacts with Atg16 to form the Atg12- Atg5- Atg16 complex which
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possesses enhanced affinity for negatively charged lipid and help tethering the phagophores
membrane (81, 83). The membranes gradually extend and engulf the cytosolic contents and fuse
with endo-lysosome in the form of autophagosomes for degradation. The contents and the inner
membrane of the autophagosomes are degraded by the lysozymes, and the remnant are
released back into the cytoplasm for recycling (84). The induction of autophagy is relatively slow.
For example, in Drosophila adults and larvae, the autophagosomes are typically induced in the
fat body 60 minutes after starvation is initiated (85).
The major function of autophagy is to maintain cellular homeostasis and to repair
damage caused by stress such as ROS, through the constitutive or induced autophagy.
Constitutive autophagy occurs at basal levels and is used as a general mechanism for cellular
protein and organelle quality control under normal situation. The process is especially important
in cells that do not readily replicate, such as neurons, cardiac cells, and hepatocytes. In a study
by Sou et al., neural-cell specific Atg5-/- mice were created to inhibit autophagy (86). The mice
exhibited ubiquitinated protein aggregates and symptoms of neurological pathology, suggesting
that basal autophagy is critical to maintaining neural health. Induced autophagy occurs in
response to nutrient deprivation, cell stress, and numerous pharmacological reagents.
In cells undergoing nutrient deprivation, autophagy is used to break down cellular
contents into amino acids and other components, and the cells can utilize the amino acids as an
energy source (87). The importance of maintaining energy homeostasis during nutrient
deprivation was stated in the study performed by Kuma et al. (88). Here, Atg5

-/- mice

failed to

survive the period of neonatal starvation that occurs following the birth and the sudden
termination of transplacental nutrient supply. During this period, a massive increase in
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autophagy was reported in the heart muscle, diaphragm and alveolar cells of WT transgenic mice
labeled with a GFP-LC3 marker (88).
Autophagy could act as a pro-survival mechanism by antagonizing ROS and removing
damaged organelles such as mitochondria. As stated above, ROS surging-induced Nrf2 could bind
to ARE to increase the transcription of antioxidant-related genes, as well as autophagy-related
genes, such as P62 (89). Another major connection between ROS and autophagy is tumor
suppressor gene P53, which is also a central hub for stress signaling pathways. Under normal
circumstances, cytosolic P53 suppresses autophagy by directly interacting with FIP200 (human
ortholog of yeast Atg17) and inhibits Ulk1 complex. Increased ROS levels stimulate the
redistribution of P53 from cytosol to nucleus, and directly regulates the transcription of several
downstream genes related to autophagy, including subunits of AMPK (AMP-activated protein
kinase), which activates autophagy triggered by starvation and hypoxia, and DRAM (damage
regulated autophagy modulator), which promotes autophagy (90-93).
The reduction of cytosolic P53 also releases the suppression of Ulk1 complex and induces
the initiation of autophagy (91). At the same time, cytosolic P53 also translocates to the
mitochondrial matrix and interrupts the proton electrochemical gradients across the
mitochondrial membrane, thus reducing the mitochondrial membrane potential (ΔΨm). The
reduction of ΔΨm may cause the selective autophagic removal of dysfunctional mitochondria
(94). Evidence of direct interactions between ROS and autophagy proteins has also been found.
Among the autophagy-related proteins, Atg3, Atg7 and Atg10 are the most sensitive to ROS
because they are involved in the ubiquitin-like reactions to catalyze the conjugation of PE to LC3I, which depends on the thiol group of the cysteine residue (95). The Cys81 of Atg4 is modified by
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starvation-induced ROS production, specifically H2O2, thus inducing autophagy, which is
visualized by LC3-II incorporation into the autophagosome membrane (92). Conversely, the
inhibition of autophagy may increase the formation of reactive oxidative species, as well as
increased ubiquitinated proteins and dysfunctional mitochondria (96). In summary, the above
evidence suggests that autophagy could be affected by the increase of ROS level in FRDA.
In addition to its pro-survival roles, autophagy also shows a pro-apoptosis function as a
mediator of cell death in many occasions. Autophagic cell death is accepted as a unique form of
cell death and has received the title of Type II programmed cell death (97). The cells undergoing
autophagic death exhibit an accumulation of autophagosomes in the cytoplasm. Yet the
presence of autophagosomes in the cytoplasm is not sufficient evidence to conclude that a cell is
undergoing autophagic death. Cell death can occur solely through autophagy as seen in MCF-7
cells treated with the drug tamoxifen (98). There is also evidence that autophagic cell death can
accompany apoptotic cell death, and the two pathways are not necessarily mutually exclusive.
For example, in the removal of Drosophila salivary glands in the pupae, apoptotic features such
as caspase activation and DNA fragmentation are observed alongside the accumulation of
autophagosomes (99).
Besides the above observations, it is also reported that autophagy can participate in the
activation of traditional apoptosis. For example, treatment of cells with the pan-sphingosine
kinase inhibitor SKI-I could induce apoptosis by activating caspase-8. But the absence of Atg3 or
Atg5 reduces the caspase-8 activation. Young and colleagues found that Atg5 could facilitate
apoptosis by forming a complex with caspase 8, FAS-associated death domain (FADD) and
activating caspase-8 activity (100). Recently, it was reported that intrinsic apoptosis pathways
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are activated in β-cells and neurons from FRDA rat, mediated by Bcl-2 family proteins Bad, DP5,
and Bim (101). Mincheva-Tasheva et al. found induced apoptosis in the primary cultured
neurons from FRDA rat dorsal root ganglion (DRG). They also found that the apoptosis could be
reverted by the addition of BH4 domains from Bcl-xL protein, which inhibits autophagy through
inhibitory interaction with Beclin-1/Atg6 (102). It is intriguing to explore if autophagy is involved
in the loss of neurons, cardiomyocytes or other cell types in FRDA patients by promoting
apoptosis under a certain level of stress. The above data suggest that the autophagy could
function in anti-apoptosis and/or pro-apoptosis ways in FRDA.
Currently, there are several autophagy modification chemicals available, including
inducers and inhibitors, and some of them have been tested in clinical trials or therapies. The
canonical autophagy inducer is rapamycin (sirolimus), a fungicide with immunosuppressive
property (103). Rapamycin affects autophagy by forming complex with cytosolic FKBP12 proteins
and destabilizing mTOR complex, thus activating Ulk1 complex for autophagy initiation (104).
Another chemical, methylthioninium chloride, also named methylene blue (MB), was also
discovered to be a strong inducer of autophagy. The report suggested that MB stimulates
autophagy through the activation of AMPK, possibly by inhibiting mTOR and activating the Ulk1
complex to initiate autophagy (105). At the same time, MB also reduces the phosphorylation
level of Insulin Response Substrate (IRS), which in turn activates Insulin-like Growth Factor (IGF)
receptor and the Phosphoinositide 3-kinase (PI3K). PI3k next phosphorylates Akt, which
inhibitorily phosphorylates GSK-3 to lower its activity, thus facilitates the interaction of Bif-1 and
BECN-1, leading to the formation of an SH3GLB1-BECN1 complex that activates PI3K to increase
autophagy (106).
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On the other hand, common autophagy inhibitors include chloroquine (CQ), bafilomycin
A1, and 3-methyladenine (3-MA). CQ inhibits autophagy by altering the pH of the lysosome to
interfere

with

lysosomal

acidification,

resulting

in

interrupted

degradation

of

autophagosomes/autolysosomes (107). Similarly, bafilomycin A1 suppresses autophagy by
blocking the vacuolar type H+-ATPase on the lysosomal membrane to disrupt the lysosome
acidification and autophagosome/lysosome fusion (108). The function of 3-MA comes from its
interaction with class III phosphatidylinoside-3-Kinase (PI3K) which inhibits the production of
phosphatidylinositol 3-phosphate (PI3P), thus suppressing the recruitment of Atg proteins to the
phagophore during the initiation stage (109). These modifiers provide us with powerful tools to
study autophagy in FRDA.
1.2.2

Mitochondria Homeostasis and Mitophagy in Neurodegenerative Diseases and FRDA
Beside the quantification of autophagy in FRDA, we are also interested in the detailed

mechanism of autophagy in FRDA progression. Currently, it is not clear the downstream events
of the increased ROS and Fe-S cluster dysregulation in FRDA. The details of how autophagy
affects neurons and cardiac cells in those neurodegenerative diseases are still unclear and
sometimes controversial. As mentioned before, autophagy participates in the regulation of
protein and organelle degradation, especially in the long-lived postmitotic cells like
cardiomyocytes and neurons. Autophagy has been proven to be one of the major mechanisms in
degrading aggregation of misfolded proteins in Alzheimer’s disease, Parkinson’s disease, and
amyotrophic lateral sclerosis (110). We hypothesize that the autophagy could play a role in FRDA
by affecting mitochondrial homeostasis, inducing apoptosis, or initiating mitophagy. In other
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words, autophagy could be the link between mitochondrial dysfunction and the
neurodegeneration and neuron loss in FRDA.
As the powerhouse of the cells, mitochondria are subject to the ROS damages results
from oxidative stress in diseases, including FRDA (111). When mitochondrial functions are
interrupted, they become the major source of ROS production such as H2O2 and O2•- (112,
113). The damaged mitochondria usually show up-regulated ROS production (114). Considering
that Frataxin is localized in the matrix, the mitochondria are the direct target of the cellular
stress and hence raise the possibility that the mitochondrial could be an important factor in
FRDA pathogenesis.
Defective mitochondria have been recognized as a key feature of Friedreich’s ataxia. The
deletion of yeast Frataxin homolog YDL120 reduced the mitochondrial respiration ability up to
40% compared to WT [26]. B. Amoros and colleagues reported that reduced Frataxin in SH-SY5Y
human neuroblastoma cells caused dysfunctional mitochondria (43). The lower ATP production
(50% or less), reduced Cytochrome C oxidase 1 and 2 (Cox I/ II) protein level and increased
depolarization of mitochondrial membrane potential (reduced ΔΨm) were observed in SH-SY5Y
cells (43). The lowered mitochondrial membrane potential was confirmed by Mincheva-Tasheva
et al., who showed that in cultured DRG neurons, 5 days after the Frataxin KD, there is a
significant reduction of mitochondrial membrane potential (102).
It was reported that by measuring the ratio of citrate synthase and aconitase activities,
the mitochondrial respiratory chain activity shows 84% decrease in FRDA patients’ heart samples
(43). In the meantime, the abnormal iron contents inside the mitochondria were 8-12 times
higher than the WT cells. The same pattern was observed in human FRDA patients. Iron
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accumulation is also seen in heart samples from FRDA mouse (115). There were changes in
mitochondrial morphology and reductions in mitochondria numbers, as well as an increase in
mitochondrial fusion (43). But until today, the research of mitochondrial homeostasis in FRDA is
relatively limited and often controversial.
Several hypotheses were developed in the connection between dysfunctional
mitochondria and FRDA, including the involvement of mitochondria induced apoptosis and the
defects in mitochondrial quality control (MQC) pathways, such as fission/fusion and, to our most
interest, mitophagy (101, 116-118). As stated above, autophagy could participate in type I or
type II cell death, and the induced apoptosis of neuron cells has long been associated with
neurodegenerative diseases. For example, Magrane et al. showed that morphologically altered
mitochondria accumulate in familial amyotrophic lateral sclerosis (fALS) transgenic rat motor
neurons right before the neuron death (119).
It is still unclear about the connection between dysfunctional mitochondria and FRDA
pathological symptoms such as neuron degeneration and myocardial cell loss. Multiple studies
explored the possibility of apoptosis mediated by Frataxin deficiency in those cell types, but the
results were controversial. Increased apoptosis was reported in rat DRGs neurons and was
observed in Frataxin-deficient clonal rat INS-1E β-cells, and inducible Pluripotent Stem Cell
(iPSC)-derived neurons originated from FRDA patients (102) (101). Bolinches-Amoros et.al
observed limited proliferation rate and shorter survival time in Frataxin KD SH-SY5Y cell lines.
The Frataxin KD cells showed a higher level of senescence related β-galactosidase (SA-β-gal)
activities but no changes in apoptosis-related cytosolic cytochrome C contents and the overall
active form of caspase-3 in Frataxin-KD cells. The conclusion was that Frataxin depletion
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accelerates cell senescence but does not induce apoptosis. However, this finding is partially
shadowed by the fact that the finding was observed in the SH-SY5Y neuroblastoma cell line, of
which the anti-apoptotic property may produce bias while performing apoptosis assay (43). The
debate on the mitochondrial homeostasis and possible mitochondrial induced apoptosis in FRDA
will require more research in the future.
Given the importance of providing essential energy for maintaining cellular activities,
mitochondria are strictly monitored by multiple levels of MQC mechanisms. Different strategies
of MQC are used against various types of stress. MQC can remove damaged mitochondria
through mitochondrial fission/fusion to reduce the stress in the anti-apoptotic direction. While
mitochondrial fission and division lead to apoptosis, mitochondrial fusion usually protects the
cell against apoptosis (120, 121). Under other circumstances, MQC would promote
mitochondrial fragmentation and mitochondrial autophagy (mitophagy) for energy and material
recycling, as well as the aforementioned induced apoptosis. The presence of dysfunctional
mitochondria in FRDA shows a possible absence or dysregulation of MQC, which may be caused
by iron deposits and defective MQC components, or limited MQC capacity compared with
increased abnormal mitochondria (122). We are especially interested in the function of
mitophagy in FRDA.
It has been confirmed that increased mitophagy occurs in Alzheimer ’s disease, which
indicates that abnormal autophagy activities are associated with neurodegenerative diseases
[44]. Evidence showed that the mitochondria, either healthy or dysfunctional, could be found in
autophagosomes in rat hepatic cells (123). Studies conducted in S. cerevisiae verified that the
strains with Atg mutations, including Atg1, Atg6, Atg8, and Atg12, show defects in mitochondrial
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degradation (124). Lower mitochondrial electron transport chain activities and higher levels of
ROS are detected in those strains, which were similar to FRDA symptoms, showing the
importance of mitophagy in maintaining mitochondrial functions (125).
Mitophagy, the removal of mitochondria through autophagy is considered selective. The
specificity of mitophagy is confirmed by targeting the mitochondria through photo damaging
agents. Chan et al. observed that in mouse lung cells with increased oxidative stress, GFP-LC3
highly co-localized with RFP-labelled citrate synthase, a mitochondrial protein, indicating the
removal of the damaged mitochondria through mitophagy (126, 127). Starvation followed by
glucagon supplementation activates the engulfment of mitochondria with several fold increase
of autophagosomes, indicating the selective removal of depolarized mitochondria through
mitophagy (128). Starvation also increases the amount of autophagosomes and autolysosomes
that co-localize with mitochondria remnants (129).
It has been shown that it takes about 6 minutes for the mitochondria to be engulfed by
phagophores or pre-autophagosomes (130). The sequestered mitochondria depolarize within 10
minutes by losing their fluorescent signal after Tetra-methyl-rhodamine-methy-lester (TMRM)
treatment, a dye fluoresces when mitochondria are depolarized (130). The real-time analysis
reveals that it takes an average of 7 minutes to digest the mitochondria after their sequestration
into the autophagosomes (129).
Two major proteins involved in mitophagy are E3 ubiquitin ligase Parkin, which is
encoded by Park2, and PTEN-induced putative kinase Pink1. When the depolarized ΔΨm is
detected, Parkin re-distributes from the cytosol to the mitochondria, and is accompanied by the
loss of mitochondrial markers such as Tom20, Cytochrome C, and TNF receptor-associated
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protein 1 (TRAP1) (131). Pink1 is rapidly degraded by presenilin-associated rhomboid-like
protein, a rhomboid protease in healthy mitochondria. But in dysfunctional mitochondria with
diminished membrane potential, Pink1 is stabilized on the outer mitochondrial membrane while
forming complexes and recruiting Parkin (132, 133). Research suggests that Pink1 recruits Parkin
through its cytoplasmic kinase domain by phosphorylating Parkin at its Thr175 and Thr217 sites
(134). The recruited Parkin then induces ubiquitination of mitochondrial membrane proteins
such as VDAC and Mitofusin1/2, which promotes the degradation of the mitochondrial
membrane and the following mitophagy (135-137).
Research also indicates that Parkin could induce mitochondrial fragmentation to facilitate
mitophagy, by degrading mitochondrial protein Mitofusin 1 and 2 by proteasomes (138). The
mitophagy regulation signaling pathways are extensively studied, and multiple genes are linked
to the events. The Dynamin-related protein 1 (Drp1), which is recruited to the outer
mitochondrial membrane, was reported to initiate mitophagy by binding to the mitochondrial
outer membrane protein Fission 1 (Fis1).

The deficiency of Drp1 causes diminished

mitochondrial function in respiratory function and ATP production, as well as lost mtDNA. Most
importantly, mitophagy in Drp1–KD cells is suppressed (139). On the other hand, Drp1 overexpression promotes mitochondria elimination by promoting mitophagy (140). It is possible that
Drp1-dependent mitochondrial fragmentation primes mitophagy (141).
An interesting discovery is that the mitochondria, after a cycle of fusion/fission, can be
divided into two categories: those that undergo refusion and those that do not (142). Currently,
it is not clear what sorting mechanism is behind these two subpopulations (143). Generally,
fission produced two subpopulations of mitochondria. Ones with lowered membrane potential
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(ΔΨm) tend to incorporate with autophagosomes for degradation The other ones with higher
potential remain in the cytosol for possible fusion(142). Mitochondria that never undergo refusion show a lower ΔΨm and tend to co-localize with LC3-GFP labeled autophagosomes,
implying the possibility that mitophagy is the destination of unsalvageable mitochondria (144).
The depolarized mitochondria are observed to be sequestered in the autophagosomes by
the lysosomal inhibitor Pepstatin A and E64D (144). Optic atrophy 1 (OPA1) is also considered to
regulate mitophagy since the over-expression of OPA1 can effectively reduce the mitochondrial
fraction in autophagosomes (145). Recent findings also suggest that mutated NIX, which encodes
a BH3 family protein, reduces the presence of mitochondria in autophagosomes. The NIX-/reticulocytes containing mitochondria are more sensitive towards stress from anemia, implying
that the inability of removing malfunctioning mitochondria may be detrimental to the cell (146).
Currently, NIX, ULK1, and Parkin are identified as signals that could specifically activate
mitophagy in mammalian cells (147). In addition, some Atg genes may also participate in the
regulation of mitochondria degradation. For example, knockdown of Atg7 reduces mitochondria
removal in K562 cells. It is interesting to note that the KD of the essential Atg5 gene does not
impede mitophagy in reticulocytes from neonatal animals (147).
In summary, the function of mitophagy has been associated with other
neurodegenerative diseases such as Parkinson’s disease, but not in FRDA yet. We are interested
in testing the status and possible role of mitophagy in FRDA Drosophila models.
1.2.3

Drosophila models of cardiovascular disease and FRDA
Drosophila melanogaster is used extensively as a model system for genetics and

developmental studies. It has the great advantages of low cost and a short generation time (2
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weeks). More importantly, the homologs of 75% of known human disease genes can be found in
Drosophila, which implies that the knowledge obtained from the Drosophila model is
transferable to humans (148). The genome projects of high-density P-element and PiggyBac
element insertions throughout the Drosophila genome make it an even more powerful model
organism (149, 150). The understanding of numerous diseases has benefited from the
Drosophila model, including Parkinson’s disease, diabetes, cancer and, especially, heart disease
(151).
The Drosophila heart (dorsal vessel) is morphologically different from the vertebrate
heart but is evolutionarily conserved (152). In the Drosophila open circulatory system, the
heart is defined as the section of the dorsal vessel between abdominal segments A5-A8 (153).
The section anterior to the heart is a narrow tube called the aorta, which expands from thoracic
segment T3 to abdominal segment A5 (153). In Drosophila pupae, the heart tube consists of two
layers of cells. The inner cell layer contains two rows of myocardial cells, which form the tightlyjointed inner surface for contractile functions and with ostia cells in between which permit the
entrance or exit of hemolymph (Drosophila blood) (153, 154). The relatively loosely organized
outer layer has two rows of pericardial cells with possible excretion functions. The myocardial
cells can be distinguished by their expression patterns of tinman (Tin). The homeobox gene
tinman is expressed in each segment of the dorsal vessel and in four of the six pairs of cardial
cells. Its expression patterns provide a powerful tool for researchers to investigate the cardiac
function and development in the Drosophila model.
In Drosophila, different forms of cardiac dysfunction were observed such as cardiac
arrhythmias, including atrial fibrillation and cardiac arrest (152). In addition, there are plenty of
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well-established Drosophila techniques available, including edge-measurement microscopy and
electrical pacing methods (155, 156). The recent development of optical coherence tomography
(OCT) provides nondestructive and noninvasive ways to detect the in vivo cardiac morphological
changes, which is difficult to achieve in mammalian models (151). By optically tracking the
movement of both edges of the heart, OCT examines the heart rate and contractile function by
measuring differences in diastole and systole diameter at the same point in time. OCT can be
used to calculate the contractile velocity by determining the heart tube diameter changes in a
certain time frame, using video recording and picture analysis software. In addition, external
stress sources, such as square-wave electric pacing and chemical treatments can be applied to
the Drosophila heart before and during the optical analysis.
The frequency of stress-induced permanent or temporary arrests and the uncoordinated
contraction of heart tubes, which is similar to atrial fibrillation in vertebrates, can be calculated
as a measure of cardiac function (157). The effectiveness of cardiac assays in Drosophila has
been proven in many publications. Occor et al. found that a KD mutation in the KCNQ potassium
channel in myocardial cells increased the sensitivity to pacing-induced heart failure, which
mimics the effects of aging (158). Wessells et al. investigated the role of insulin-IGF receptor
signaling pathways for the reduction of cardiac function during the aging process. While the
heart rate decreased and pacing-induced heart failure rate increased with aging, the cardiac
function could be restored by overexpressing the phosphatase dPTEN or the transcription factor
dFOXO (159).
Friedreich’s ataxia affects not only the central nervous system but also other organs,
especially the heart. Because of its high energy demand and extensive mitochondria enrichment,
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the heart is one of the most affected organs in FRDA cases. Iron overload cardiomyopathy is the
one of the leading causes of cardiovascular mortality in FRDA patient (160). Heart diseases in
FRDA patients may be severe, which contributes to the disability and premature death,
particularly in early-onset cases (161). A study conducted by Harding et al. found that among 115
FRDA patients, more than 2/3 acquire the signs of cardiomyopathy. Other frequent symptoms
included shortness of breath (in 40% of patients) and palpitations (in 11% of patients) (30).
In one of the most sensitive investigations for FRDA-associated cardiomyopathy,
electrocardiography shows inverted T-waves in virtually all patients and ventricular hypertrophy
in most patients (162). Around 5-10% of the patients are affected by atrial fibrillation (AF),
which is one of the most common cardiac arrhythmias and usually leads to increased risk of
cardiovascular mortality and stroke (163, 164). Studies show that various hypertrophic
cardiomyopathies are present in almost all FRDA patients (165). Over 50% of the FRDA patients
will eventually die from the complications associated with heart disease, which makes cardiac
malfunction a leading cause of FRDA patients’ death (125, 166). In a survey of FRDA patients
lethality, Tsou and colleagues reported 59% of the deaths in their FRDA samples were caused by
cardiac dysfunction, which causes earlier death than in non-cardiac FRDA patients (median death
age 29 vs. 17). Among deceased FRDA patients, the cardiomyopathy of FRDA includes congestive
heart failure (29.5%), arrhythmias-related (16%), ischemic heart diseases (4.9%), and atrial
fibrillation related stroke (6.6%) (167).
Genetically, the deterioration of hypertrophic cardiomyopathy is associated with the size
of repeat expansion in the smaller allele of Frataxin (21). Some observations of postmortem
FRDA patients’ heart tissue made by Michael and colleagues showed that, besides the muscle
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fiber necrosis and increased tissue scars, there were also perinuclear iron deposit granules
accumulating between myofibrils. However, the total cellular iron in the left ventricular wall in
FRDA patients is similar to control cells (168). Together with the findings of increased electron
density of mitochondrial deposits, it pointed to the possibility that the mitochondrial damage is
induced by iron deposits. It speculated that iron deposits lead to muscle fiber necrosis and
myocarditis (168). Mottram et al. showed reduced left ventricular volume and increased
thickness of the left ventricular wall in FRDA patients, as well as impaired peak systolic and atrial
velocities. The peak systolic and early diastolic level were both reduced in FRDA cases (169).
Research in animal models confirmed the findings that peak systolic and early diastolic
level were both reduced in FRDA cases. For example, Puccio et al constructed two conditional
Frataxin-deficient mouse lines, in which the mutant Frataxin allele is driven by tissue-specific Cre
transgene controlled by either muscle creatine kinase (MCK) or neuron-specific enolase (NSE)
promoters. The achieved muscle specific deficient FRDA mouse line, which has a heterozygous
mutant allele of Frataxin in cardiac muscles, showed reduced left ventricular contractile
function, both systolic and diastolic. The heart rate and the blood flow velocity in the ascending
aorta were also reduced in the FRDA mouse model compared to control mouse (170, 171). Vyas
and colleagues showed ultrastructure cardiac results of Frataxin KD mouse with disrupted arrays
of sarcomeres and abnormally shaped mitochondria while the normal mouse heart shows
orderly arranged myofibrils with uniformly shaped mitochondria (170).
From the views of biochemistry and molecular pathology, the data from the Frataxin
knockout fibroblast and mouse model constructed by Vyas et al. showed that the aconitase
protein level and activity in whole heart were reduced (170). Aconitase is a mitochondrial
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enzyme that is especially sensitive to inactivation by oxidative stress. The numbers of
mitochondria in FRDA cardiomyocytes are widely increased with decreased number of
myofibrils. There is nearly a 10-fold increase in activated caspase-3 positive cell staining, which
suggestsa a possible increase in mouse cardiomyocytes apoptosis (170). All of the above data
suggest that the Frataxin deficiency causes severe damage to the heart in FRDA. We are
interested in finding if the heart damage also occurs in Drosophila and if it is related to the
autophagy.
In addition to the Frataxin deficiency, the condition of Frataxin overexpression is also
interesting. In mammalian cells such as 3T3-L1 preadipose cells and mouse models, the
overexpression has shown no adverse effects (172, 173). However, aforementioned
overexpression of either human or Drosophila Frataxin impairs the nervous system and brain
function, as well as locomotive ability (174). This indicates the Frataxin may be involved in
different cellular response pathways under different concentrations. It is not clear how the
Frataxin over-expression models relate to the symptoms present in FRDA patients since overexpression has never been observed in patients. But since the overexpression situation is a
potential danger in gene therapy, the study of Frataxin overexpression status will be helpful for
future research.
1.3

AMPK and SAPK stress response pathway are involved in inducing autophagy in FXN-KD

Drosophila
Increased autophagy could reduce the stress level by removing damaged organelles, thus
enhance the tolerance towards stress. On the other hand, increased autophagy could promote
autophagic death/apoptosis in the cells and cause malfunction of certain tissues. So we assume

27
that the stress response pathway may participate in autophagy regulation. It is known that
autophagy activation from oxidative stress is controlled primarily at two critical hubs:
mammalian target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK). Under
conditions of low intracellular energy, activated AMPK induces autophagy both by
phosphorylating Ulk1 for activation and by inhibiting mTOR complex 1 (mTORC1) via direct
phosphorylation of mTOR binding partner raptor (175).
The other important stress response pathway involves stress-activated protein kinase
(SAPK/JNK) signaling pathways. In Alzheimer’s diseases, the interaction of abnormal
mitochondria and oxidative stress response elements induces the production of oxygen species
in dysfunctional neurons, which in turn activates SAPK as a long-term stress-responsive
mechanism (176). Research in the intestinal epithelium showed that oxidative stress can induce
autophagy requiring JNK signaling (177). The activation of JNK in the intestinal cells can increase
autophagy and induce the expression of several Atg genes (178). Further details about the
involvement of AMPK/SAPK in FRDA requires more research.
Until now, a lot of work has been done on the effect of ROS in FRDA patients, but very
few studies have investigated the fate of the malfunctioning mitochondria. My goal of the
project is to determine whether the mitophagy process is altered in FRDA KD Drosophila.
Considering that autophagy is also deemed as the major mechanism against oxidative stress as
stated above, we propose that autophagy plays a significant role in the pathogenesis of FRDA in
two possible ways: promoting apoptosis in certain cell types or removing damaged mitochondria
through mitophagy, separately or combined. Our work will be the first to examine the possible
role of turnover of damaged mitochondria through mitophagy in FRDA. If it is confirmed that the
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mitophagy is affected in FRDA Drosophila, the manipulation of autophagy or mitophagy might be
a possible direction for FRDA therapy.
2. Statement of Problem
Currently, a lot of work has been done on the mechanisms of how Frataxin deficiency
affects FRDA patients. The role of Frataxin in iron sulfur cluster synthesis and in maintaining
normal mitochondrial function has been well explored. However few details are available about
the downstream activities of dysfunctional mitochondria due to the Frataxin reduction, such as
the fate of the malfunctioning mitochondria, and status of mitochondria quality control
mechanisms. As one of the major anti-stress response pathways and the damaged organelle
removal mechanisms, the dynamic of autophagy under Frataxin deficiency is intriguing. Our
work will be the first to examine the turnover of damaged mitochondria through mitophagy in
FRDA. If it is confirmed that the mitophagy is affected in FRDA Drosophila, the manipulation of
autophagy or mitophagy might be a possible direction for FRDA Therapy.
3. Materials and Methods

Drosophila culture: Drosophila strains: UAS-fh.IR (w[1]; P (w[+mC]=UAS-fh.IR)2), UAS-fh.wt (w[1];
P(w[+mC]=UAS-fh.A),1), UAS-Atg1.IR (y1 v1; P{TRiP.JF02273}attP2), w[*]; P(w[+mW.hs]=GAL4da.G32)UH1, UAS-GFP.IR, and FXN-D (Bl3694, Df(1)9a4-5, y[1] cv[1] v[1] f[1] car[1]/FM7C) were
obtained from Bloomington Stocking Center. The GMH5-Gal4 stock was a gift from Dr. Robert
Wessells. All Drosophila strains were maintained in 23 ml plastic vials on Bloomington recipe for
Drosophila Medium. The vials were kept in the incubator of 18°C or 25°C and 50% relative
humidity. Each vial were transferred to a new vial every 3-4 days. UAS-fh.IR or W1118 was used
as a control strain.
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Starvation and chemical treatment: Starvation was initiated by transferring Drosophila into an
empty vial with a cotton ball containing 4 ml H2O at the bottom to avoid dehydration. Numbers
of surviving Drosophila were counted every 24 hours and recorded. Chemical treatments were
using chemical incorporated medium in which the chemicals were dissolved in distilled water
according to the different final concentrations of 1 liter medium. The dissolved solutions were
added to food medium at 55°C during preparation. The medium was stirred for even distribution
before poured into vials. For small quantity chemical treatments or reagents that were fragile to
heat, such as rapamycin, the chemicals were dissolved in ethanol and add to 6% sucrose
solution. Drosophila were transferred to vials containing cotton balls with 3ml of sucrose
solution. Drosophila were transferred to new vials with the same treatment every four days.
Locomotive Assay: For each experiment, 10 adult Drosophila 24 hours after eclosion were placed
in one 30 cm graduated cylinder that were evenly marked for three parts: bottom, middle, and
top sections. The Drosophila were placed in the cylinder for 5 minutes before the test. Next the
Drosophila were gently knocked down to the bottom of the cylinder and the numbers of
Drosophila climbing up to each section in 10 seconds was recorded. The experiment for each
group was repeated three times.
Real-Time PCR: Certain amount of Drosophila were homogenized in Trizol reagent from
Invitrogen (Carlsbad, CA). RNA was extracted using the RNeasy mini kit from Qiagen
(Hombrechtikon, Switzerland). The acquired RNA contents were quantified using Nanodrop
(Wilmington, DE). The cDNA was synthesized using 20ng mRNA by oligo (dT) primers and
Superscript III reverse transcriptase from Invitrogen (Carlsbad, CA). The Taqman primer
sequences were adopted from previous publications and purchased from Applied Biosystems
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(Foster City, CA). The PCR reaction was performed using Taqman PCR Master Mix and the ABI
7500 PCR machine. The thermal cycling conditions were 95°C for 10minutes, 45 cycles at 95°C
for 15 seconds/60°C for 60 seconds. The results were normalized by using internal controls such
as GAPDH and 18s rRNA. The Ct (Cycle of threshold) value was detected automatically, and the
relevant RNA abundance was calculated by ABI software.
Immunostaining: Each 2 ml Eppendorf tube contained 20 larvae or 15 pupae, or 15 adults that
were quickly frozen at -20°C after collection. The samples were homogenized in liquid nitrogen
for 1 minute. Then 200 ul of Pierce RIPA lysis buffer (Thermo) with protease and phosphatase
inhibitors (1:100, Thermo) was added to each vial and homogenizes for another 60 seconds. The
samples were sonicated for 10-15 seconds and centrifuged for 15 minutes at 4°C and 15000
rpms. The supernatants were collected for acetone precipitation to remove extra lipids, salts,
polysaccharides, etc. Briefly, 4X sample volume of -20°C acetone was added to the supernatant.
The tubes were vortexed for 10 seconds and incubated for 10 minutes at -70°C. The vials were
then centrifuged 10 minutes at 13000 g and 4°C. The supernatants were carefully removed, and
the vials were air dried for 5 min. The pellets were dissolved in 200 ul RIPA buffer with protease
and phosphatase inhibitor and quantified using the Bradford method. The proteins were
separated by SDS-PAGE 4-20% precast gradient polyacrylamide gels (Bio-Rad) and then
transferred to nitrocellulose membranes using a semi-dry transfer machine (Bio-Rad). The
membranes were hybridized using primary antibody and HRP second antibody stained by
luminol solution (GE). The results were imaged and analyzed by ImageJ software.
Measurement of heart rates and diastole/systole diameter: Methods was adopted from Wessells
et.al (179). For each group, 50 gender and age-matched Drosophila from both mutant and
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control strain were tested. The Drosophila were anesthetized by FlyNap (Carolina Biological
Supply, Inc.) for 4 minutes and placed on the soft gel on top of the slice with the abdomen
toward the light source. Each slice contained 8 Drosophila and the slice was placed under the
microscope. The beating of each individual heart was recorded. For the purpose of precision, the
measurement is performed on the first cardiac ventricle of the heart tube. For each Drosophila, a
10-second movie was recorded. The video was reviewed later, and the results were presented as
beats per minute. The end-diastolic and end-systolic dimensions were measured on the still
images from the movie clips. The position is chosen at the midpoint between two of the major
transversal tracheal tubes passing through the first cardiac ventricle.
Electrical pacing: For each treatment group, the data of 50 male and 50 female Drosophila were
collected. For the pacing, 50 Drosophila were anesthetized by FlyNap (Carolina Biological Supply,
Inc.) anesthetizer for 4 minutes. Then the Drosophila were placed between two electrodes
touching conductive gel spread over the electrodes. The hearts were shocked with a square
wave stimulator (Phipps & Bird, Inc.) producing a current for 40 V and 6 Hz for 30 seconds. Heart
failure rate is defined as the percentage of Drosophila that enter either cardiac arrest or
fibrillation during or immediately after the pacing. The recovery rate is defined as the number of
Drosophila return to normal after pacing-induced arrest or fibrillation within 2 minutes of pacing
cessation. Total recovery indicates the proportion of Drosophila with normal heartbeat 2 min
after cessation of pacing. During each pacing, 8 Drosophila were treated and recorded using
Nikon NIS-Elements Advanced Research System. For each genotype, the data of 50 Drosophila
were collected within 50 minutes to avoid the variation of anesthesia status. Each strain was
repeated three times.
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Statistical analysis: Experiments will be conducted in triplicates to reduce variation, except where
noted. The data will be analyzed as Mean ± SEM in those experiments that had triplicates. In the
experiments where duplicates were done, the spread was shown but p-value significance was
not determined because it cannot be done with n = 2. A one-way analysis of variance (ANOVA)
was performed to compare between groups, when indicated.
4. Results
4.1

Construction of Frataxin-deficient and overexpression Drosophila
To test the autophagy activity in Frataxin-deficient and overexpression Drosophila, we

obtained Drosophila stocks of Frataxin partially knock-down, Frataxin deficiency, and Frataxin
overexpression. We used two types of Frataxin-deficient Drosophila. The Frataxin-deficient stock
(BL3694, Df(1)9a4-5, y[1] cv[1] v[1] f[1] car[1]/FM7C) ,termed FXN-D line, was obtained from
Bloomington Drosophila Stock Center. It contained segment deletion on X chromosome, from
8C7 to 8E2. The deleted Frataxin gene was located at 8C14. The absence of the segment was
balanced by balancer chromosome FM7C. The homozygous deficient progeny did not survive.
Female heterozygous-deficient progeny are viable and fertile with a reduced Frataxin expression
level.
The Frataxin partial knock-down line daG32-fh.IR termed FXN-KD, was achieved using the
UAS-Gal4 system (180). The Drosophila UAS-Gal4 system had been established for many years
because of its versatility and convenience to manipulate gene expression. The ubiquitous or
tissue specific expression of Gal4 proteins bind to the UAS promoter region to start the
transcription of the inverted repeat product, a hairpin RNA which will be processed later by Dicer
complex through siRNA pathways and will target and degrade endogenous Frataxin mRNA at
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certain tissues. The UAS stocks that carried an inverted repeat sequence of Frataxin was UASfh.IR (w[1]; P{w[+mC]=UAS-fh.IR}2 ) and was constructed by Anderson in 2005 (181). The other
available Frataxin knock-down strain produced by Anderson is w1; P{UAS-fh.IR}1, which contains
the insertion on the third chromosome. Because this stock is weak, and the survival rate is
extremely low even at 18 degrees, we used the stocks with 2nd chromosome insertion for the
following work. The inverted repeat sequences were located on the 2nd chromosome of UASfh.IR strains. For the driver Drosophila stocks, we used daG32-Gal4 lines for whole body
expression, which contains a daughterless (da) gene promoter that ubiquitously expresses the
target gene in all tissues at a very high level. We also obtained Frataxin overexpressing
Drosophila by crossing UAS-fh.wt (w[1]; P{w[+mC]=UAS-fh.A}1) stocks that carry wild-type
Frataxin sequences to a daG32-Gal4 promoter stocks. For comparison, Atg1 deficient line, UASAtg1.IR (y1 v1; P {TRiP.JF02273} attP2) was also obtained by crossing with promoter strains to
provide negative controls for the investigation. Previous studies show that the GAL4 activity was
properly initiated at 16°C, and 29°C provides the maximal effects without jeopardizing the
viability and fertility of the fruit Drosophila. In our study, the original stocks were stored,
collected, and crossed at 25 0C. The crossed strains which are larvae/pupal lethal stocks were
crossed and raised at 18 0C until they developed into adults. The tests were performed at 25 0C
in the adults.
4.2

Characterization of FXN-KD stock
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By crossing the daG32-Gal4 driver stock with Frataxin knock down stock (UAS-fh.IR), we
obtained Frataxin partial knockdown Drosophila, daG32-fh.IR. The parental stocks, daG32-Gal4 and
UAS-fh.IR, are viable, fertile, and with normal life span at 18 oC and 25 oC, which indicates the
daughterless gene, and the insertion of inverted repeat sequences did not affect the Drosophila

Ubiquitous

18 oC

25 oC

29 oC

daG32_fh.IR

√

×

×

daG32_ Atg1.IR

√

×

×

daG32_ fh.wt

√

√

×

daG32_ GFP.IR

√

√

√

Table 1: Viability of daG32-Gal4 driven Drosophila strains under different temperatures. The
ubiquitously expressed Gal4 strain daG32-Gal4 was crossed with different target strains in
one of the three temperatures for diverse efficiency. The survival phenotype is indicated as
“√” symbol while the lethal phenotype is indicated as “X” symbol. Frataxin inverted repeat
containing strain, UAS-fh.IR (w[1]; P[w[+mC]=UAS-fh.IR]2 ) was crossed with daG32-Gal4 to
obtain Frataxin KD daG32-fh.IR strain. The progeny survived at 18°C, but not 25°C and 29°C.
Similar results were observed in Atg1 KD daG32-Atg1.IR strains

viability and fertility. The progeny daG32-fh.IR Drosophila are viable and fertile at 18oC. At 25oC
the daG32-fh.IR Drosophila are viable through larval stage with a high lethality rate before pupal
stage, while 100% of the pupal development terminated in late pupal stage (Table 1). The size of
the larvae are larger compared to the control strain before the development stops. The result is
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in accordance with the description from Anderson et al that the Frataxin deficiency causes
shorter life span, high rates of early termination, and late pupal lethality (181).
The partially KD adults are viable and could be collected at 18oC, but the survival rate is
very low. The collected adults have lifespans of about 7-14 days at 18oC. When they were
transferred to 25oC immediately after collection, they had a much shorter longevity about 24-72
hours, with few escapers that can survive up to 5 days (Figure 1). The difference in the longevity
is possibly due to the siRNA efficacy of the UAS-Gal4 system, which was more efficient at 25oC
than at 18oC. The Frataxin mRNA level was reduced to a lower level at 25oC compared to that of
18oC, which produce more deleterious effects such as lower survival rate and shorter longevity.
The results showed that the daG32-fh.IR Drosophila have the phenotypes of Frataxin
deficiency matching the previous reported Frataxin knock-down studies. To avoid the possibility
of unspecific effects of Gal4 protein or the inverted repeat structure in the siRNA, we also tested
the daG32-Gal4 and daG32-GFP.IR lines, which ubiquitously silence the GFP gene as negative
controls. Both lines were viable, fertile, and within the normal range of lifespan in both 18 and
25oC. It excluded the non-specific influence of Gal4 protein and inverted repeat insertion.
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To exclude the possibility of Frataxin siRNA off-target effects, we crossed the UAS-fh.wt
stocks, which carried an allele of wild type Frataxin, with the UAS-fh.IR siRNA stock, and the
lethal phenotypes were partially rescued. But one of the constructs, UAS-FF2-h, which contains a
recombinant chromosome carries both wild-type Frataxin allele (UAS-fh) and the short hairpin
frataxin allele stock (UAS-fh.IR). When crossed to daG32–Gal4, its progeny, daG32-FF2-h, showed
10-fold overexpressed Frataxin mRNA levels, but nevertheless displayed similar phenotypes to
the FXN-KD Drosophila. The overexpression is possibly caused by the insertion of multiple copies
of wild type Frataxin allele during construction. A similar strategy was applied by Anderson et. al
and their cross rescued the knock-down phenotypes. We concluded that the daG32-fh.IR fit into
the description of the original knock-down strain and the Frataxin knock down is effective.

Figure 1: Frataxin reduction significantly reduce the life span of Drosophila The longevity and
survival assay for control (UAS-fh.IR) and FXN-KD (daG32-fh.IR) Drosophila at 25°C showed that
FXN-KD Drosophila have a lower survival rate. Control and FXN-KD adult Drosophila from 18 oC
were immediately transferred and maintained in 25oC for 10 days.
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Next, we performed a series of assays to measure the impact of Frataxin reduction on
daG32-fh.IR Drosophila. First, we tested the longevity of partially Frataxin knock-down Drosophila.
The adult daG32-fh.IR Drosophila were collected from eclosion within 24 hours at 18oC and
transferred immediately into incubation at 25oC. The Drosophila were transiently transferred to
new vials every 72 hours at room temperature and immediately returned to 25oC. The
daG32_fh.IR Drosophila show significant shorter life span compared to UAS-fh.IR adult Drosophila
at 25oC (Figure 1). It confirmed the essential role of Frataxin in maintaining normal survival and
development of the Drosophila.
Because one of the defects of Frataxin deficiency is progressive mobility deterioration,
we measured the locomotive ability of control and daG32-fh.IR Drosophila through mobility assay.
Briefly, 10 1-day old Drosophila were placed in a 19 cm gradient cyclinder at room temperature.
The cylinder was evenly marked into 3 sections: top, middle, and bottom. The Drosophila were
tapped down to the bottom of the tube and were given 10 seconds to climb to the top base on
their anti-gravity instinct. After 10 seconds, the numbers of the Drosophila stayed at each
section were recorded. The high percentage of flies to stay on the top section indicated stronger
locomotive ability. The adult Drosophila of FXN-KD at 1 day of age showed lower percentage to
be able to stay on the top section of the cyclinder during climbing assays, which indicate reduced
mobility in Frataxin reduced Drosophila (Figure 2). The shorter longevity and lower mobility
resembled the features of human FRDA patients.
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Figure 2: Climbing assay confirms the declined locomotor ability in FRDA Drosophila. The
assay was performed using a 2.4cm diameter and 19cm high glass measuring cylinder.
The column is demarcated evenly into three sections: Bottom, Mid, and Top. At 24 hours
after eclosion, two groups of 10 Drosophila from each phenotype were tested for three
times individually. The Drosophila were allowed for 10 seconds movement, and the
numbers of the Drosophila that stay in each section will be counted and calculated to
show their mobility. Both male and female FXN-KD showed lower locomotive activity
comparing to Control (UAS-fh.IR) Drosophila
Next, we used quantitative real time-PCR (qRT-PCR) to measure the Frataxin knock down
level in daG32-fh.IR Drosophila. The test was carried out on adult Drosophila collected from 18oC
and immediately transferred to 25oC for 24 hours. The Frataxin mRNA level was reduced 50% in
female Drosophila and 30% in male Drosophila at the age of 24 hours (Figure 3). Because the
further reduction of Frataxin would be lethal for daG32-fh.IR Drosophila, we consider this
moderately knock-down Frataxin Drosophila to be a proper FRDA model. The western blot
showed that the Frataxin protein levels in female daG32-fh.IR Drosophila are also reduced
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compared to the control Drosophila, which indicates the successful knock down of Frataxin
through RNAi (Figure 4).

Figure 3: TaqMan Real-Time PCR (qRT-PCR) showed the Frataxin mRNA levels were reduced in
FXN-KD Drosophila 24 hours after eclosion at 25 degrees. The Drosophila eclosed at 18oC and
were immediately transferred to 25oC and maintained for 24 hrs. Each sample were pooled
using 20 files and were homogenized and extracted for mRNA. For PCR, each sample with
three technical repeats was tested and plotted for comparison. The FXN-KD females showed
more than 50% reduction of Frataxin mRNA compared to controls (p < 0.001). The FXN-KD
males showed about 25% reduction in mRNA compared to control males (p < 0.01).
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Figure 4: Frataxin protein expression is decreased in FXN-KD female Drosophila at 25 oC. The
Drosophila eclosed at 18 oC were immediately transferred to 25 oC and maintained for 24 hrs
before tests. Ten Drosophila were pooled for each sample. The daG32-fh.IR female showed
less Frataxin protein compared to UAS-fh.IR control females.
4.3

Autophagy is upregulated in Frataxin partial knock down daG32-fh.IR Drosophila
Next, we characterized the autophagy activity in daG32-fh.IR Drosophila. First we

measured FXN-KD Drosophila’s mRNA level of Atg1 and Atg5. Atg1 is a protein kinase which
plays a key role in the initiating autophagy. The Atg1 knock down stock, daG32-Atg1.IR, was used
as a positive control. The RT-PCR results of daG32-fh.IR adult Drosophila 24 hours after eclosion
showed that Atg1 mRNA level in was up-regulated 100% in female Drosophila, and over 30% in
male Drosophila, indicating the increased initiation of autophagy when Frataxin is reduced
(Figure 5 A). As positive control, the realtime-PCR results showed that Atg1 mRNA level in daG32Atg1.IR Drosophila was decreased to less than 50%.
The mRNA level of Atg5, which is another marker for autophagy activity, was also
examined. We do not observe dramatic change of Atg5 mRNA levels compared to the controls in
the female and male daG32-fh.IR Drosophila (Figure 5:B). The explanation could be that the Atg5
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transcription level does not change in Frataxin deficiency. Another explanation for the relatively
stable transcription level is that the Atg5 is downstream of Atg1 in the expanding stage of the
autophagy pathway, parallel to the LC3/Atg8 branch. The results indicate that the Frataxin
deficiency does induce autophagy increase in the transcriptional stage in daG32-fh.IR Drosophila,
and may be associated with Atg5 independent autophagy mechanisms.
The most convincing marker for the autophagy activation is the level of Atg8 protein,

Figure 5: The measurement of Atg1 and Atg5 mRNA levels in FXN-KD adult Drosophila 24
hours after eclosion. The Atg1 KD strain, daG32-Atg1.IR was used as positive control. The
Drosophila eclosed in 18 oC were immediately transferred to 25 oC and maintaining for 24
hrs. Each sample containing 10 adult Drosophila were homogenized in lysis buffer. The
mRNA were extracted and quantified by Nanodrop. (A) The FXN-KD female showed 90%
increase of Atg1 mRNA compared to UAS-fh.IR controls(p < 0.001), while The FXN-KD male
Drosophila showed 30% increase in Atg1 mRNA compared to control (p<0.001). The Atg1
KD female and male Drosophila both showed 70% reduction in Atg1 mRNA (p < 0.001). (B)
The female FXN-KD Drosophila showed relatively decreased Atg5 mRNA compared to
control in female Drosophila. The male FXN-KD Drosophila showed unchanged Atg5 mRNA
compared to control males. Both male and female Atg1 KD Drosophila showed increased
Atg5 mRNA level (p<0.01) and (p<0.05).
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Figure 6: Atg8 a/b protein levels increase in FXN-KD larvae. Third stage larvae were collected at
25 oC. Each sample contained 20 larvae and was homogenized in lysis buffer. Proteins were
extracted, purified and quantified by the Bradford Method(3). The ratio of Atg8/Actin was used
to determine the relative Atg8 protein level. The daG32-fh.IR females showed a 2-fold increase in
Atg8 total protein and over three-fold increase in Atg8-II protein, which indicates the quantity
of autophagosomes, compared to control larvae.
which indicates the quantity of 1autophagosome formation (182). Atg8a indicates the
unlipidated form of Atg8, which is free, cytosolic form dissociated from autophagosomes.
Atg8b is the lipidated and autophagosome-membrane-bound form. We performed western blot
on Atg8 to compare its levels between Frataxin deficiency stocks vs control Drosophila in
different development stages, including larvae, pupae, and adults 24 hours after eclosion. In the
larval stage, we found that daG32-fh.IR showed higher level of both Atg8a and Atg8b protein. The
quantification of Atg8 showed that the daG32-fh.IR had three-fold more Atg8 protein compared
to control Drosophila while Atg8b also had more than three-fold up-regulation in the larval stage
(Figure 6). The increase of Atg8 proteins in larval stages of FXN-KD implicated the
autophagosome accumulation and upregulated autophagy activity in the Frataxin deficiency
Drosophila.
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Next, we tested the Atg8 protein level in daG32-fh.IR pupae. Because the observed pupae
development termination in daG32-fh.IR, we collected pupae at 48 hours after the pupation, right
before the termination at the dark pupal stage. The western blot showed that the Atg8a is
moderately increased in daG32-fh.IR pupae while the Atg8b exhibits 2.5 fold increases compared
to control Drosophila (Figure 7). The increase in Atg8b indicated the upregulation of autophagy
in the Frataxin deficiency in the pupal stage.

Figure 7: Atg8 protein level increases in FXN-KD pupae. White pupae were collected at 25 oC.
Each sample contained 20 pupae and was homogenized in lysis buffer. Proteins were
extracted and quantified. The ratio of Atg8/Actin was used to determine the relative Atg8
protein level. The FXN-KD showed a 150% increase in Atg8-II protein compared to UASfh.IRcontrol pupae.
The adult stage FXN-KD Drosophila were tested too. The daG32-fh.IR female Drosophila
and control Drosophila. The western blot results showed that FXN-KD female Drosophila showed
higher Atg8 level than UAS-fh.IR Drosophila (Figure 8), confirmed that Frataxin deficiency induces
autophagy in all developmental stages.
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Along with Atg8 levels, we also found that another Atg family member, Autophagy
related 16-like 1 (Atg16 L1) protein level was up-regulated in FXN-KD compared to UAS-fh.IR
Drosophila, which provide further support for the autophagy activation in Frataxin partial
knockdown Drosophila (Figure 9).

Figure 8: The Atg8 protein level increases in FXN-KD adults 24 hours after eclosion. The FXNKD showed significantly higher levels of Atg8 protein than the control W1118
Drosophila.The FXN-KD Drosophila were eclosed at 18oC, immediately transferred to 25oC
and maintained for 24 hrs. Each sample contained 20 larvae and was homogenized in lysis
buffer for western blot.
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Figure 9: The protein level of Atg16 increases in daG32-fh.IR larvae. The daG32-fh.IR and
UAS-fh.IR strains were maintained and tested at 25oC. Each sample contained 20 3rd
instar larvae and was homogenized in 200 ul lysis buffer. Proteins were extracted,
purified and quantified by the Bradford Method. The daG32-fh.IR showed increased
Atg16L1 protein level compared to controls. It indicated up-regulation of autophagy
activities in daG32-fh.IR Drosophila.

To further test the status of autophagy in Frataxin deficiency, another Frataxin Xchromosome deficiency strain FXN-D (Df(1)9a4-5, y[1] cv[1] v[1] f[1] car[1]/FM7C) was also
tested. Since only the FXN-D adult females are hemizygous for Frataxin deficiency, we compared
the Atg8 protein level between FXN-D and w1118 female adults. The western blot results
showed that FXN-D female Drosophila showed higher Atg8 protein level than W1118 Drosophila,
confirming that Frataxin deficiency induces autophagy (Figure 10). The similar results from two
different Frataxin reduction stocks supported the upregulation of autophagy induction in the
Frataxin deficiency Drosophila.

46

Figure 10: The Atg8 protein level increases in Frataxin deficiency (FXN-D) adult females.
(A) The FXN-D female showed less Frataxin protein compared to W1118 control
females. (B)The FXN-D females showed significantly increased Atg8 protein level
compared to control (p < 0.05), indicating a higher level of autophagy. The total
protein was shown to be approximately equivalent by Ponceau S staining. The FXN-D
and control strains were maintained at 25 oC. Each sample contained 10 files and was
homogenized in lysis buffer. Proteins were extracted, purified and quantified by the
Bradford Method.
Then we asked the question: what is the function of autophagy in Frataxin deficiency
Drosophila? Based on previous research, there are two possible theories. First, the autophagy
could have a anti-oxidative and pro-survival role in Frataxin deficiency Drosophila. Treatment of
autophagy inducer should increase the longevity of FXN-KD Drosophila while an autophagy
inhibitor should show negative effect on the FXN-KD Drosophila. We treated the daG32-fh.IR with
media that contains autophagy inducer methylene blue (MB), concentrations of 0.1 µM, 0.5 µM,
1.0 µM, 5.0 µM, and 10 µM. The treatment of UAS-fh.IR control Drosophila in MB does not
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shown difference up to 7 days after eclosion from 0.1 uM to 0.5 uM ( Figure 11). The higher dose
of MB from 1.0 to 5.0 uM showed certain level of toxicity by reducing the larvae survivor number
and pupae formation. Together it showed that the autophagy induced by MB does not affect
wild type Drosophila, especially in lower doses.
But when we crossed UAS-fh.IR and daG32-fh.IR in media containing 0.1 µM, 0.5 µM, 1.0
µM, and up to 5.0 µM MB at 25 oC, the outcomes were different according to the concentration.
In lower doses of MB from 0.1 µM to 0.5 µM, we observed significant less death rates of 2nd and
3rd stage larvae compared to that of control media. The number of 3rd stage larvae was directly
associated with the concentration of MB between 0.1 µM and 0.5 µM. More pupae were formed
in 0.1-0.5 uM range, which indicates the beneficial effect of induced autophagy. But none of the
lower doses of MB treatments were able to rescue the papae lethal phenotype.
When the concentration of MB increased to 1.0 µM and 5.0 µM, we found that almost
100% daG32-fh.IR larvae die before they reach 3rd stage. Very few 2nd stage larvae and no pupae
were formed (Figure 1B). The beneficial effect of low concentration and the deleterious effect of
high concentration of MB may indicate that mild induction of autophagy could partially rescue
the phenotype of FXN-KD larvae while the over-induction of autophagy will produce contrary
effect. Although the induction of autophagy cannot rescue the pupal lethal phenotype in daG32fhIR Drosophila, this piece of evidence supported that induction of autophagy within certain
ranges could act as protective role in Frataxin deficiency Drosophila.
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Figure 11: Autophagy inducer Methylene Blue treatment partially rescues the larval lethal rates
of daG32-fhIR larvae. (A) 0.1-0.5uM methylene blue does not affect larvae viability and pupae
formation rate in UAS-fh.IR Drosophila. The treatment of 0.1-0.5uM MB does not affect the
larvae viability and pupae formation rate, while 1.0 uM and 5.0 uM concentration showed
increased toxicity by reducing the number of larvae and pupae. The methylene blue was
dissolved in ethanol and added to the media to the final concentration of 0.1uM, 0.5uM,
1.0uM and 5.0uM. For each concentration, 3 vials were tested, including control vials with
normal media. 10 female and 10 male of UAS-fh.IR Drosophila were maintained in each vial for
48 hours and then removed. The vials containing eggs were cultured in 25oC. The number of
newly emerged larvae and pupae were recorded daily (B) The 0.1-0.5uM methylene blue
restored larvae viability and pupae formation rate in FXN-KD Drosophila. The 1.0 uM and 5.0
uM MB showed reduced number of larvae and pupae. The media preparation is stated above.
For each concentration, 3 vials were tested, including control vials with normal media. In each
vial, 10 virgin female UAS-fh.IR and 10 male da-Gal4 were maintained for 48 hours and then
removed. The vials containing eggs were cultured in 25oC. (C) The Frataxin overexpression
daG32-FF2-h did not affected by MB treatment at 0.1 and 0.5 uM, but the larvae survival rate
and pupae formation were reduced at higher MB concentration at 1.0 and 5.0uM. For each
vial, 10 virgin female of UAS-FF2-h and 10 male da-Gal4 Drosophila were maintained in each
vial for 48 hours and then removed. The vials containing eggs were cultured in 25oC.

4.4

Apoptosis is induced in FXN-KD larvae
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Because FRDA features accelerated loss of the sensory neurons in DSG, it is reasonable to
question if an abnormal apoptosis process is involved in the progression of FRDA (183). However,
current findings about apoptosis in FRDA are limited and controversial. It is found that the
apoptotic cell death is observed in rats’ primary DSG cells in a rat FRDA model (102). Mariana
et.al reported that the Frataxin knock-down human iPSC derived neurons, and rat β-cells show
signs of intrinsic apoptotic pathway activation (101). Our findings of early development
termination in both larval and pupal stage in daG32-fh.IR Drosophila also implicated the possible
role of apoptosis in FRDA Drosophila. It is interesting that although Frataxin is generally
considered a protective role in cells by anti-oxidative stress and DNA damages, recent evidence
also revealed its role as tumor-suppressor by promoting apoptosis (184).
Based on the above evidence, we asked whether the Frataxin deficiency could trigger the
increased apoptosis in the FRDA Drosophila, and whether it is through the induction of
autophagic cell death (Type II apopotosis). So we hypothesized that Frataxin deficiency induces
apoptosis and causes the increment of caspase-3 and possibly cytochrome C, which is a
mitochondrial protein related intrinsic apoptosis pathway, in FXN-KD Drosophila. First we tested
the apoptosis marker caspase-3 levels in FXN-KD Drosophila vs. control Drosophila. The western
blot results showed that daG32-fh.IR larvae showed a significant increase of cleaved caspase-3,
indicating up-regulation of apoptosis pathways in Frataxin-deficient larvae (Figure 12).
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Figure 12: The protein level of apoptosis-related activated caspase-3 increases in da-fh.IR
FXN-KD) larvae. The protein level of apoptosis-related activated caspase-3 increases in
daG32-fh.IR (FXN-KD) larvae. It showed that adult female Drosophila contain a higher level
of cleaved caspase-3, indicating a higher level of apoptosis. Two different repeats are
shown with HSP60 as the loading control. The FXN-KD and control strains were
maintained in 25oC. Each sample containing 10 Drosophila was homogenized in lysis
buffer. Proteins were extracted, purified and quantified by the Bradford method.
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Because Frataxin deficiency is closely associated with mitochondrial homeostasis and apoptosis,
we decided to test if the apoptosis is activated through intrinsic pathway. A previous study
showed when the apoptosis pathways were triggered, mitochondrial cytochrome C were
released into cytosol and bound with Apaf-1 and caspase-9 to cleave and activate caspase-3
protein for apoptosis (185). The western blot results showed that in the daG32-fh.IR larvae and
pupae, total cytochrome C was significantly higher than the control Drosophila in both stages
(Figure 12 and Figure 13), indicating an increase of cytochrome C level in the Frataxin deficiency
Drosophila early developmental stages. It implied the increase of apoptosis in FRDA Drosophila is
through intrinsic pathway. In summary, the deficiency of the Frataxin deficiency induced
apoptosis in FRDA Drosophila, possibly through intrinsic pathways.

Figure 11: The protein level of cytochrome C increases in daG32-fh.IR (FXN-KD) larvae. The
apoptosis-related cytochrome C protein in the larvae of FXN-KD Drosophila was
upregulated, but not significantly, indicating a possible higher level of apoptosis. Two
different replicates are shown with HSP60 as the loading control. The FXN-KD and UASfh.IR control trains were maintained at 25oC. Each sample contained 20 whole larvae and
was homogenized in lysis buffer. Proteins were extracted, purified and quantified by the
Bradford method.
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Figure 12: The protein level of cytochrome C increases in pupae of daG32-fh.IR (FXN-KD).
The apoptosis-related cytochrome C in the pupae of FXN-KD Drosophila was upregulated,
although not significant, indicating a possible higher level of apoptosis. Two different
replicates are shown with HSP60 as the loading control. The FXN-KD and control UAS-fh.IR
strains were maintained at 25oC. Each sample contained 20 pupae and was homogenized
in lysis buffer. Proteins were extracted, purified and quantified by the Bradford method.
4.5

Autophagy is induced in Frataxin-overexpression daG32-FF2-h Drosophila
Our previous study showed detrimental phenotype in FRDA Drosophila, so we decided to

test if overexpressing wildtype Frataxin in Frataxin deficiency background could rescue the
phenotypes such as larval and pupae lethal. We crossed the UAS-FF2-h stock with daG32-Gal4 to
obtain the Frataxin overexpressing daG32-FF2-h progeny. The progeny was pupal lethal at 25oC
and had normal fertility and viability at 18oC. Real-time PCR showed that daG32-FF2-h Drosophila
have over 10 folds Frataxin mRNA level compared to control Drosophila, in both genders (Figure
14). Considering the abnormal fertility and viability of daG32-FF2-h Drosophila in 25oC, the
significant Frataxin overexpression negatively affected Drosophila viability and fertility, similar to
the Frataxin deficiency Drosophila. In summary, both Frataxin deficiency and overexpression in a
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large scale both negatively impact the survival rate and longevity of Drosophila.

Figure 13: The Frataxin mRNA level increase in Frataxin overexpressing (daG32-FF2-h)
Drosophila 24 hours after eclosion. The Frataxin mRNA level increase in Frataxin
overexpressing (daG32-FF2-h) Drosophila 24 hours after eclosion. The Frataxin
overexpressing female showed 12 fold increase of Frataxin mRNA compared to control (p <
0.001) while Frataxin overexpression male showed a 15-fold increase over control males (p
< 0.001). The Drosophila eclosed at 18 oC and were immediately transferred to 25 oC and
maintained for 24 hrs. Each sample contained 10 Drosophila and was homogenized in lysis
buffer. The mRNA was extracted, purified and quantified by Nanodrop. The experiments
were done in triplicate. *, p-value<0.05; **, p-value < 0.01; ***, p-value < 0.001. The
significance symbols are the same for all of the gene expression figures that follow.
To assess if Frataxin overexpression is associated with autophagy alterations, we
compared Atg1 and Atg5 mRNA levels in daG32-FF2-h Frataxin-overexpression Drosophila and
control UAS-FF2-h Drosophila. The real-time PCR results showed that Atg1 mRNA level increased
about 2.5-fold and 3-fold compared to female and male control Drosophila. The Atg1 level in
Frataxin overexpression Drosophila was 25% and 80% higher than that of Frataxin-deficient
Drosophila (Figure 15A). When comparing Atg5 mRNA levels, we found that similar to Frataxin-
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deficient Drosophila, Frataxin overexpression Drosophila do not show a significant increase in
Atg5 transcription levels. On the contrary, the Atg5 mRNA was reduced in both male and female
daG32-FF2-h Drosophila (Figure 15B). Based on the above results, we concluded that the
overexpression of Frataxin in Drosophila increases Atg1 mRNA but does not change Atg5 mRNA.

Figure 14: The mRNA level of Atg1 and Atg5 genes in FXN-KD and overexpression Drosophila.
(a) Atg1 mRNA levels in Frataxin-deficient (daG32-fh.IR), overexpressing (daG32 –FF2-h), and
UAS-fh.IR control adult Drosophila 24 hours after eclosion are different. The Atg1 KD strain,
daG32 -Atg1.IR was used as positive control. The Frataxin overexpressing female showed
150% increase in Atg1 mRNA while FXN-KD Drosophila showed 100% increase in Atg1
mRNA compared to control adults (p < 0.001). The FXN-KD male Drosophila showed 30%
increase in Atg1 mRNA compared to WT (p<0.001) while Frataxin overexpressing
Drosophila showed a 200% increase in Atg1 mRNA compared to control male Drosophila.
(b) Atg5 mRNA level in FXN-KD, daG32 –FF2-h, and control adult Drosophila 24 hours after
eclosion. The female Frataxin overexpressing Drosophila showed about 15% reduction in
Atg5 mRNA (p<0.05) compared to control females, similar to FXN-KD females. The male
Frataxin overexpressing Drosophila showed 25% reduction in Atg5 mRNA compared to
control males (p<0.01). The Drosophila eclosed at 18oC and were immediately transferred
to 25oC and maintaining for 24 hours Each sample contained 20 larvae and was
homogenized in lysis buffer for PCR.
We also treated the daG32-FF2-h Drosophila with autophagy inducer MB. The Frataxin
overexpression daG32-FF2-h were not distintly affected by MB treatment at 0.1 and 0.5 uM, but
the larvae survival rate and pupae formation were greatly reduced at higher MB concentration at
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1.0 and 5.0uM, showing further increase of autophagy would be detrimental (Figure 11C).
4.6

Pathways of mitochondrial quality control and mitophagy in FRDA Drosophila
As mentioned before, damage of mitochondria was intensively studied in FRDA. It is still

not clear about the possible events downstream of dysfunctional mitochondria. Based on our our
results, we asked the question that if the changes of autophagy are associated with
mitochondrial function or the mitochondrial autophagy (mitophagy), a major mechanism to
remove damaged mitochondria. First, we examined the status of mitochondria in FXN-KD. The
levels of two mitochondrial proteins were tested. The mitochondrial matrix protein Hsp60 was
measured as mitochondrial quantity while the pyruvate dehydrogenase is measured as an
indicator of mitochondrial function. The western blot results showed that the Hsp60 protein level
remains stable in FXN-KD larvae compared to controls, in both 18 oC and 25 oC, suggesting that
the quantity of mitochondria does not change (Figure 16). The pyruvate dehydrogenase protein
level, however, was reduced in daG32-fh.IR at 25oC, suggesting a possible dysfunction of the
mitochondria (Figure 16) and matches the description from previous research of mitochondria in
FRDA models.
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Figure 15: The protein level of Hsp60 and pyruvate dehydrogenase in daG32-fh.IR (FXN-KD)
larvae. The results showed that the mitochondrial marker Hsp60 does not change, but the
amount of pyruvate dehydrogenase is reduced in FXN-KD Drosophila, indicating possible
functional loss in the mitochondrial respiratory chain, but the mitochondrial quality is not
altered.
Next, we tested the level of mitophagy by mitophagy marker protein Parkin, whose level
usually increases upon environmental stress factors, in 24 hours old FXN-KD Drosophila. The
results showed that the level of Parkin is slightly but not significantly increased in daG32-fh.IR
adult Drosophila (Figure 17). It is also possible that the Parkin does not change dramatically in
translational level during the induction of mitophagy, but changes the distribution between
cytosolic and mitochondrial.
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Figure 16: The mitophagy related protein Parkin is not changed in da-fh.IR adult
Drosophila. The adult Drosophila were collected right after eclosion and maintained 24
hours at 25oC. The whole-Drosophila protein was extracted and purified. The
concentration of Parkin was measured by the ratio of Parkin/HSP60 with duplicate.
4.7

Heart functions are not changed in Frataxin-deficient Drosophila
One of the most distinct features of FRDA patients is high rates of cardiomyopathy

incidences (30). So we attempted to test if the Drosophila heart function in Frataxin deficiency
Drosophila is also affected using heart pacing assay (156). We chose to perform the heart assay

Figure 17: The Heart Pacing Assay in da-fh.IR Drosophila at 24 hours and 48 hours after
eclosion. The KD-FXN female Drosophila showed reduced heart failure rate at 24 hours of
age compared to control female Drosophila, but the differences is not significant at 48
hours. The male KD-FXN Drosophila showed higher heart failure rate at 24 hours of age
compared to control males but not at 48 hours of age. The adult Drosophila were
collected right after eclosion and maintained 24 hours at 25oC. In each group, 50
Drosophila were anesthetized with flynap and electrically pacing for 10 seconds at 20
Volts under microscope.
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on two different Frataxin deficiency stocks, the ubiquitous Frataxin knock-down strain FXN-KD
daG32-fh.IR and the heart-specific Frataxin knock down strain GMH5-fh.IR. To obtain the GMH5fh.IR, we crossed the UAS-fh.IR Drosophila with heart-specific GMH5-Gal4 Drosophila (Gift from
Dr. Wessells) to get the GMH5-fh.IR Drosophila, which were normal in viability and fertility at
25oC. In summary, we did not observe a significant difference in stress-induced heart failure rate
between daG32-fh.IR and control Drosophila at 24 hours and 48 hours after eclosion (Figure 18).
The same result was observed on the GMH5-fh.IR Drosophila with a very high variation range.
Our explanation is that the strength of the heart pacing assay may be too intense to distinguish
the chronical cardiac changes between Frataxin deficiency Drosophila and control Drosophila.
4.8

AMPK, but not pSAPK was upregulated in Frataxin Deficiency Drosophila
The above data of our study showed increased autophagy in Frataxin deficiency

Drosophila and its possible relationship with apoptosis and mitophagy. We are also interested in
the upstream events that may be inducing autophagy. As one of the central controller of the
oxidative stress response, AMPK is associated with autophagy induction by phosphorylating and
activating Atg1, under stress or starvation condition (186). First, we examined the level of
phosphorylated AMPK in FXN-D Drosophila 24 hours after eclosion because AMPK is activated
through phosphorylation. We measured the phosphorylated AMPK (pAMPK) level in hemizygous
Frataxin deficiency FXN-D female Drosophila vs. FXN-D male Drosophila as a control. The test was
performed in both whole-body and heads (neurons) from adults 24 hours after eclosion. The
results showed that the pAMPK level is increased in FXN-D females, in both whole body and
neurons (Figure 19). It indicated the increased phosphorylation level of AMPK in the whole body
and neurons in Frataxin deficiency Drosophila. The similar expression pattern of pAMPK and Atg8
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suggests a possible role of AMPK in regulating autophagy in FXN-D Drosophila.
Besides AMPK, the other stress regulating pathway, the SAPK pathway, also attract our
attention. It is proposed that neurons in Alzheimer disease are exposed to low, but chronic, levels
of oxidative stress that lead neurons to elicit adaptive responses such as the activation of stressactivated protein kinase pathways (SAPK) (187). We tested the level of phosphorylated SAPK
(pSAPK) in FXN-KD Drosophila at 24 hours after eclosion. The result shows the level of pSAPK in
FXN-KD is not changed (Figure 20). This may indicate the change of Frataxin level in FXN-KD
Drosophila does not alter the phosphorylation status of SAPK. In summary, the experiments

Figure 18: pAMPK level increases in FXN-D adult Drosophila. FXN-D male and female
Drosophila at the age of 1 day were collected. The protein was extracted and detected
using beta-Actin and Phospho-AMPK-α (Thr 172) antibody (1:500). The ratio of
pAMPK/Beta-Actin was recorded.

60
showed that the increase of pAMPK was observed in Frataxin deficiency Drosophila, but not the
pSAPK level.

Figure 19: pSAPK protein level is not changed in daG32-fh.IR Drosophila. FXN-KD male and
female Drosophila at the age of 1 day were collected. The protein were extracted and
detected using beta-Actin and Phospho-SAPK/JNK (Thr183/Tyr185) antibody (1:500).
The ratio of pSAPK/Beta-Actin were recorded.
5. Discussion
As an evolutionarily conserved process, autophagy plays an important role in many
biological activities. To investigate its involvement in Drosophila FRDA model, we first obtained
two Frataxin deficiency stocks, daG32-fh.IR, which expresses an inverted repeat hairpin RNA of
Frataxin gene under control of Gal4, which we term FXN-KD, and FXN-D, which is a deficiency
stock. The FXN-KD efficiently reduced the Frataxin mRNA and protein levels to 50-70% and 40%,
respectively, from real-time PCR and Western blot results. The percentage of reduction in the
Drosophila model resembles the Frataxin protein levels in FRDA patients, which is around 40-70%
percent reduction (11). A review of recent studies of Frataxin KD experiments from other
laboratories shows that the viable KD strains maintain an average of 25%-50% protein levels
compared with wild-type levels. The KD efficiency in existing FXN-KD mouse models and cell lines
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vary from 20%-80% (171, 188). The further reduction of Frataxin in Drosophila by up-regulating
the expression of the UAS-Gal4 system from 18C to 25 oC renders premature death of daG32-fh.IR
pupae. So the 60% reduction in Frataxin protein level in our model could be deemed an effective
KD.
The reduced longevity and diminished mobility in FXN-KD Drosophila may be due to the
increasing accumulation of oxidative stress damage from the Frataxin reduction. This is in
accordance with the results obtained by Anderson et.al in 2005 (181). This result proved the
constructed daG32-fh.IR line resembles the phenotype in human FRDA patients. Since the UASGAL4 system depends on the siRNA pathway, we constructed control strains to avoid the effects
from hairpin RNA. The daG32-GFP.IR showed normal longevity and fertility in 25oC, proving the
daughterless gene from daG32-Gal4 strains and inverted repeat hairpin RNA structure do not
interfere with control Drosophila. For further confirmation of the Frataxin knock down deficiency,
we also tested the FXN-D deficiency strains with hemizygous Frataxin allele deficiency. Although
the FXN-D strain has better fertility, the similar phenotypes in longevity and locomotive ability
proves that the defects are associated with the Frataxin deficiency, which proves the daG32-fh.IR
and FXN-D Drosophila qualify for FRDA model animals for the following works.
The autophagy has been closely associated with ROS metabolism and mitochondrial
homeostasis in FRDA patients and other model systems. We are the first lab to characterize and
quantify the autophagy in FXN-KD Drosophila models. We detected an increase of Atg1 in
transcription level in FXN-KD daG32-fh.IR adult Drosophila that were 24 hours old. It has been
reported that the BmAtg1 (the Atg1 homologue in silkworm, Bombyx mori) mRNA increased 50%
to 400% in different stages in the fat body of silkworms under starvation compared to control
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samples (189). The Ulk1 mRNA level doubles when the drug Baicalein induces autophagy
in HT29, HCT116, MCF7 and U373-MG cell lines (190). So the observed increase of Atg1 mRNA
strongly supports that autophagy activity is induced in FXN-KD Drosophila.
On the other hand, the mRNA level of Atg5, another essential gene for autophagy, did not
change in FXN-KD Drosophila. It is possible that Atg5 mRNA level does not change significantly
Previous studies showed that Atg5 mRNA and protein levels increase when the oxidative stress
level increases in rats (191). One possible explanation is that the induction of autophagy in FRDA
may be through the Atg5-independent pathway which is regulated by Ulk1 and beclin-1. This
Atg5/Atg7 independent autophagy pathway in mouse MEFs was described at 2009 and 2014 by
Nishida and colleagues (157, 192). In the lens of the mouse’s eye, Atg5 knockout did not affect
the organelle degradation, which also indicates the existence of Atg5 independent autophagy
pathway (193). Although currently it is no evidence that such pathway exists in Drosophila, the
further study will be helpful to examine if the relatively unchanged Atg5 mRNA levels in the FXNKD Drosophila model is a result of the Atg5/Atg7 independent autophagy induction pathways.
The western blot results showed an increase of autophagy marker Atg8a/b protein levels
in FXN-KD. The increased levels of both Atg8a and Atg8b proteins in all stages (larvae, pupae, and
adult) indicated the accumulation of autophagosomes, which indicating up-regulation of
autophagy in FXN-KD and FXN-D Drosophila. We also tested the level of Atg16, and it showed
signs of increase. Although the increase is not significant, the increase served as another line of
proof for the upregulation of autophagy.
After the confirmation of autophagy increase, we further looked into the possible
functions of autophagy in Frataxin deficiency Drosophila model. We decided to observe the
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effect of autophagy inhibitors and inducers on the Frataxin deficiency Drosophila. Our results
indicate that inhibitor chloroquine reduced the longevity of FXN-KD Drosophila while autophagy
inducer methylene blue increased the longevity of FXN-KD and FXN-D, showing a protective role
of autophagy in Frataxin deficiency. But increased concentration of MB could not be able to
increase the survival rate of pupal lethal in FXN-KD at 25OC. Additionally, when the lower
concentration of MB (0.1 to 0.5 uM) reduced the lethal rates and increased number of 3rd instar
FXN-KD in larvae, higher concentration of MB (1.0-5.0 uM) showed limited number of survival
larvae and no sign of 3rd instar lavae and pupae. This indicates that the protective mechanism of
autophagy induced by Frataxin deficiency may be affected by multiple factors, and further
research is required.
In the MB treatment experiments, we observed that when the concentration of MB
increases to more than 5 µM, the beneficial effect on FXN-KD Drosophila diminished. The FXN-KD
Drosophila in a higher concentration of MB showed high levels of early larval lethal rates and
resembled the high lethal rate in non-treatment FXN-KD larvae at 25oC. So we hypothesize that
the Frataxin-deficiency may induce apoptosis in certain stages, possibly through autophagy. Our
test confirmed that apoptosis marker, cleaved caspase-3 protein levels are significantly increased
in the third larval stage of FXN-KD with 97-99% lethal rate. The following test showed the
increase of cytochrome C indicating the increased apoptosis could be due to the cytochrome C
mediated apoptosis. This type of apoptosis is originated from the damage of mitochondrial,
which is in accordance with the previous observations in FRDA samples. Further works to test the
outcome of apoptosis inhibitor and autophagy inhibitor in FXN-KD Drosophila could help one
understand the mechanisms in more detail.
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We also found that the Frataxin overexpression Drosophila, daG32-FF2-h, which have 6-10
fold higher levels of Frataxin mRNA than control, also showed an increased Atg1 mRNA level, as
well as defects in longevity. To our knowledge, this is the first time that Frataxin overexpression is
associated with autophagy upregulation. The previous studies recorded various results from
Frataxin overexpression animal models. Some research shows that the overexpression of wildtype FRDA in FRDA-mutant cells could rescue the mutant phenotype. For example, Tan et.al
showed Frataxin overexpression by transfecting Frataxin cDNA into FRDA lymphoblast, with 147%
and 85% mRNA level compared to controls, reverts the symptoms such as decreased
mitochondrial membrane potential and increased filterable mitochondrial iron (8). The Frataxin
overexpression up to 4 fold in Drosophila showed resistance to oxidative stress insults, increased
antioxidant production and extended longevity (194). Overexpression of Frataxin at 4 fold in
hearts and at 10 fold in the pancreas showed similar phenotypes as their controls and did not
show a significant difference in antagonizing DOX (doxorubicin) induced cardiotoxicity (195).
Similar to our results, there is also a study that showed that the overexpression of
Frataxin in Drosophila at high levels disrupts development (10). When the Frataxin level was
brought to 9-fold, the Drosophila had a shorter life span and reduced locomotor phenotypes.
Frataxin overexpression is also induced cell degeneration and lipid droplet accumulation in glial
cells. The sensitivity to oxidative stress damage was also increased in Frataxin over-expressing
cells, with a reduction in both aconitase activity and NDUFS3 protein level (10). Collectively, our
results showed that Frataxin high dose overexpression (10 fold) in Drosophila exhibits similar
symptoms as Frataxin-deficient Drosophila, which is in agreement with the findings of Navarro et
al. (10). As we found with FXN-KD Drosophila, we also found that Atg1 mRNA is increased in
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Frataxin overexpression Drosophila. The similarity of responses of the Atg genes at the
transcriptional level from our study indicates that both deficiency and high dose overexpression
of Frataxin in Drosophila introduces detrimental effects on longevity and locomotive activity
through autophagy activation. This piece of information will be helpful for the clinical
applications for FRDA patients.
Because previous research does not reveal the detailed outcomes of the damaged
mitochondria in FRDA, we started to look at the status of mitochondrial quality control
mechanisms in the Frataxin deficiency Drosophila, especially the mitophagy process. Since
previous reports did not find a significant reduction in mitochondrial contents despite the
extensive evidence of damage, we hypothesize that there is a potential failure in mitophagy, the
major mitochondria removal pathway. We showed the relatively stable level of HSP60 in FXN-KD
larvae, indicating the mitochondrial contents do not change significantly. Our further test of
mitochondrial protein pyruvate dehydrogenase showed decreased protein level in daG32-fh.IR
larvae at 25oC, implicating the reduction of mitochondrial function. To measure the status of
mitophagy, we tested the protein level of PARKIN in the daG32-fh.IR larvae. The level of PARKIN in
whole-cell lysate from daG32-fh.IR larvae remains the same level. This indicates the PARKIN does
not change in translation level. The test of mitochondrial membrane-bound PARKIN will be more
accurate to determine the status of mitophagy in daG32-fh.IR.
We also extended our research into the possible cardiac defects in FXN-KD Drosophila,
and whether those defects could be detected using electric heart pacing arrays. However, the
heart pacing results were inconclusive. When being paced at 20 volts, daG32-fh.IR Drosophila did
not show significant differences in the rate of heart failure and fibrillation compared to control
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Drosophila. Our explanation is that the sensitivity of the heart pacing assay may not be enough to
detect the chronical progression of heart function loss caused by Frataxin deficiency. Another
possibility is that in daG32-fh.IR Drosophila, the reduction of Frataxin in the heart may not as
much as cardiac cell specific knockout. Another work recently published by Tricoire and
colleagues, used a heart-specific Hand-GS Gal4 promoter to construct HandGS/ (fhRNAi) FRDA
Drosophila. The knockdown effect was induced by RU486 treatment in the media. Their video
imaging to measure the heart tube M-Mode patterns showed that the Frataxin reduced heart
has impaired dilatation and systolic function (196). Our work, together with their findings,
showed the value of FXN-KD Drosophila as an in vivo system for the neurodegenerative and
cardiac diseases such as FRDA.
In summary, our work shows that autophagy increases in both Frataxin deficiency and
overexpression Drosophila. The mitochondria function changes in FRDA Drosophila but the
mitophagy level does not change significantly. Our work proves the further value of the
Drosophila FRDA model in better understanding the mechanisms of this devastating disease in
humans.
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CHAPTER 2: THE DROSOPHILA TET ORTHOLOG, dTET, IS REQUIRED FOR
HYDROXYMETHYLATION OF NUCLEAR AND MITOCHONDRIAL DNA AND
ENHANCES THE POLYCOMB-MUTANT PHENOTYPE IN ADULTS
1. Introduction
1.1

DNA methylation and mitochondrial DNA.
The regulation of gene transcription by epigenetic modification during essential

developmental stages, such as cell differentiation and genomic imprinting, has drawn an
increasing amount of attention in recent years. Interest has grown dramatically after the
discovery of the importance of epigenetic reprogramming during the generation of induced
pluripotent stem cells (iPSCs). The epigenetic modification process includes DNA and histone
modification, among which DNA methylation is one of the most understood mechanisms. The
major form of DNA methylation is 5-methylation of cytosine (5-mC), which involves the addition
of a methyl group (CH3-) to the number 5 carbon of the cytosine base. 5-mC is enriched in CpG
dinucleotides, and it has been shown to be involved in transcriptional silencing, X chromosome
inactivation, normal development, and carcinogenesis (197). Recent research has revealed that
the relatively stable 5-mC pattern in stem cells is the result of a dynamic balance between DNA
methylation by DNA methyltransferase and demethylation by Dnmt1. The DNA methylation
process consists of de novo DNA methylation by DNA methyltransferase (Dnmt3a and 3b in
mammals) and maintenance of DNA methylation after DNA replication by DNA
methyltransferase 1 (Dnmt1). Dnmt3a/3b enzymes bind to unmethylated DNA sequences for de
novo methylation while Dnmt1 preferentially binds to hemi-methylated DNA strands and
methylates the 5-mC sites on the daughter strand after DNA replication (198, 199). In
comparison, however, the demethylation process, which happens largely during zygotes and the
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primordial germ cell (PGC) stage, has remained largely unknown until the recent discovery of 5hydroxymethylcytosine (5-hmC) and Ten-Eleven-Translocation (TET) family proteins which convert
5-mC to 5-hmC (200, 201). Previous studies have shown that there are two possible ways for
demethylation - passive dilution through cell replication and active removal of methylcytosine
through enzymatic reactions converting 5-mC to 5-

hmc

and further oxidative products, 5

carboxyl-cytosine (5-caC) and 5-formly-cytosine (5-fC), which is the focus of our current
research(201, 202).
1.2

DNA demethylation and hydroxymethylation
Similar to 5-mC, 5-hmC is another epigenetic DNA marker, which was found several

decades ago in T4 bacteriophage (203). In 2009, researchers discovered that 5-hmC is enriched in
mouse embryonic stem (ES) cells and Purkinje neurons (204, 205), although the role of 5hmc is
still to be elucidated. Some studies have suggested that 5-hmC is a stable epigenetic mark that is
enriched in active transcriptional promoters. Recent findings also suggested that 5-hmC may act
as an intermediate in the process of DNA active demethylation. The TET family proteins were
found to convert 5-mC to 5-hmC through α-ketoglutarate- and Fe (II) dependent dioxygenase
reactions (206).
Currently, there are three members found in the mammalian TET family: Tet1, Tet2, and
Tet3 (206). Mouse TET1 and TET2 proteins are mainly expressed in embryonic stem cells
(ESCs) while TET3s are highly expressed in germline cells (207). The conversion of 5-mC into 5-hmC
requires cofactors such as a-ketoglutarate (α-KG) and Fe (II), and vitamin C (201). Because α-KG
was produced in the mitochondrial TCA cycle by isocitrate dehydrogenase (IDH) family proteins,
we speculate that the IDH expression level is closely related to the hydroxymethylation process.
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It is reported that mutant IDH was found in several types of cancers, which could reduce the
hydroxymethylation level by irreversibly converting the TET co-factor α-kG into R-2hydroxyglutarate (R-2HG) (208). 5-hmC could be further oxidized by TET into 5-Formylcytosine (5fC)

and 5-Carboxylcytosine (5-caC)(209). The following removal of 5-fC or 5-caC through thymine-

DNA glycosylase (TDG) and the base excision repair (BER) pathway could replace the original 5mC

with unmodified cytosine, finishing the demethylation process (210), The changed 5-hmC

level and mutation of TET and IDH had been reported in multiple diseases. Genome-wide
mapping of 5-hmC showed its level was reduced in melanoma but not in benign tumors. It was
accompanied by the down-regulation of IDH2 and TET proteins, and could be rescued by
reintroducing active TET2 and IDH2 (211). The same trends were reported in breast, liver, gastric,
and colorectal cancers (212-215). At the same time, reduced 5-hmC level was correlated to the
up-regulation of TDG proteins, indicating the active demethylation process (216). But the exact
detail of this demethylation pathway is still unclear.
In addition to the role of TET protein’s essential role in demethylation pathways, recent
research has found that TET may be engaged in epigenetic modification of histones through its
partnership with O-linked

-N-acetylglucosamine (O-GlcNAc) transferase (OGT). OGT catalyses

O-GlcNAcylation through the addition of O-GlcNAc onto the hydroxyl moiety of serine/ threonine
residues through post-translational modification (217). In Drosophila, OGT is encoded by a
Polycomb Group (PcG) gene, super sex comb (sxc), located on chromosome 2R (218, 219). It
has been confirmed that both TET2 and TET3 directly interact with OGT in vivo in mammalian
cells. Yu, etc. found that in mouse ES cells.
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TET2 interacted with OGT through its carboxyl terminal catalytic double-strand β-helix
(DSBH) domain and OGT’s N-terminal tetratricopeptide repeats (TPR) 5 and 6 (220). Currently
there is no evidence that the interaction of TET and OGT altered DNA property beyond the
conversion of 5-mC to 5-hmC

because no new base modifications were detected after the

incubation of TET2 and OGT together with 5-mC in vitro (220). It was observed that when TET2
level is reduced using short hairpin RNA (shRNA) in ES cells, the interaction between OGT and
chromatin was abolished, as well as the H2B Ser112 GlcNAcylation. The conclusion was made
that TET2 might be essential for OGT’s function and its targeting on chromatin (220). Conversely,
however, when the OGT was KD with shRNA, it did not affect its function and the association
with TET2. Furthermore, the enzymatic null TET2 mutant could still interact with OGT and
maintained the GlcNAcylation, which suggests the OGT’s physical interaction with TET2, instead
of enzymatic activity, is more important for OGT function.
With the great potential of TET in both DNA and histone modifications, more work is
needed to understand better the role of TET in regulating epigenetic states. Here we
characterized the phenotype of a loss of function dTET KD Drosophila by using a powerful and
robust Drosophila model. We found that the dTET KD Drosophila had reduced 5-hmC content,
similar to the observation in mammalian models. We also showed that dTET is a Polycomb Group
protein member because it has genetic interactions with the Polycomb4 (Pc4) mutation.
Furthermore, we showed that the mitochondrial genes and genes near the chromosome 3L
telomere region have been greatly reduced in mRNA and hydroxymethylation levels in dTET KD
Drosophila.
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The jumonji C domain-containing histone lysine demethylase KDM2A was reported to
bind to unmethylated CpG in ribosomal DNA (rDNA) promoter region through its CXXC zinc
finger motif, which also presents in dTET protein, and inhibit the rDNA transcription(221).
Further investigation revealed that another KDM family member, KDM4D, requires PARP-1 and
RNA-binding to associate to DNA damage sites. Its accumulation may be related to double
strands break repair in mammal cells (222). This finding associates the change in chromatin
protein property with the activity of DNA transcription, showing that some enzymes could
regulate epigenetic changes by regulating histone and DNA at the same time.
The human mitochondrial genome is a double-stranded, circular structure of 16,569
bases. It contains two ribosomal RNAs (rRNA), 22 tRNAs, cytochrome c oxidase subunits I-III,
cytochrome b, ATPase subunit 6 and several predicted proteins coding sequences (223). The
non-coding region of the mitochondrial DNA sequences were termed D-Loop, which provides the
interaction and transcription sites for nuclear-encoded mitochondrial proteins (224). In 2008,
Zhang lab identified there are 940 mitochondrial proteins in murine cardiac cells, of which 99%
were encoded in the nucleus (225). Recently, the Lee lab reported that the mitochondrial DNA
(mtDNA) copy numbers are regulated by the methylation level of the mtDNA-specific
polymerase gamma A (POLGA) exon 2. The cancer cells and pluripotent cells were highly
methylated at the exon 2 of POLGA while possessing low mtDNA copy numbers. After the
demethylation agent treatment of 5-azacytidine for 28 days, the glioblastoma cells showed
increased mtDNA copies accompanied by decreased POLGA exon2 methylation (226). This is
another possible mechanism to regulate the expression of mitochondrial genes.
2. Statement of Problem

72
The research on 5-hmC and TET protein were dramatically expanded after the discovery of
their possible roles in active demethylation process. But the details of the involvement of TET
protein in the hydroxymethylation process is far from clear. Although TET knock-down/knock-out
animals were produced, few works were carried out in the Drosophila model. In this project, we
are characterizing the outcome of dTET (Drosophila TET) knock down in dTET deficiency
Drosophila. The epigenomic landscape of the dTET deficiency Drosophila was analysed, especially
global hydroxymethylation. Genetic crossing were performed to further explore the property of
dTET. Because the DNA repair proteins participated in the DNA active demethylation process, so
the global distribution pattern of typical DNA repair related proteins were also tested. The
outcome of this project could reveal more details of TET protein and its analogue in Drosophila,
one of the most important epigenetic models. Our findings will accelerate the understanding of
DNA active demethylation and provide insights for the future therapy for diseases such as
cancers and neurodegenerative diseases.
3. Materials and Methods
Drosphila Stocks: All of the stocks are from the Drosophila Stock Center in Bloomington, IN. :”
OgaP (y1 w67c23; ry506 P[SUPor-P]OgaKG04950); dTETEP (w1118; P[w+mC]=EP]EP995[EP995]/TM6B,Tb1);
Pcl11 (In(2R)Pcl11/SM5); ScmD1 (st1 in1 kniri-1 ScmD1/TM3,Sb1); sxc6 (OGT) (sxc6 bw1 sp1/SM1); Scr17
(Scr17/TM6B, Tb1), Df(3L)TL (dTet-Left Deficiency) (w1118; Df(3L)Exel6091, P[w+mC]=XPU]Exel6091/TM6B,Tb1), Df(3L)TR (dTet-Right Deficiency) (w1118; Df(3L)Exel6092, P[w+mC]=XPU]Exel6092/TM6B,Tb1); Df(3L)BigT (Df(3L)BSC23, rhove-1 e1/TM2, pp); w1118; KrIf-1* (made in our
lab); T(2;Y)kisL124 and Pc4 pp/TM3,Sb1 (gift from J. Kennison); mt2hw (gift from K. Maggert). In
this study, we generated the stocks: 1) T(2;Y) kisL124 ; Pc4 pp/TM3,Sb1 that was used to test for
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enhancement or suppression of the extra-sex-combs phenotype; 2) w1118; dTETEP OgaP/TM6,Tb1
which has dTET and Oga on the same chromosome; and 3) w1118; dTETRev1 /TM6,Tb1 was made by
excision of the P-element in dTETEP by crossing it to Drosophila with the genotype w1118; Sb1 (23)/TM2 (which expresses the P-element transposase), isolating F1 males with the genotype w1118;
dTETEP/Sb1 (2-3), crossing the males in individual vials to w1118 ; TM2/TM3, Sb1 virgin females,
and selecting 50 F2 Drosophila with white eyes. Three precise-excision lines, dTETRev1 , dTETRev2
and dTETRev3 , were saved and validated to be precise excisions of the P-element by PCR. The
w1118; KrIf-1 (without ELBOs) and the w1118; KrIf-1* (with ELBOs) stocks were made as described
previously (227).
Statistical analysis of RNA-Seq data: *.Fastq files for RNA Seq was aligned to the dm3 build
reference genome using TopHat2. The *.sam files were converted to *.bam files and sorted
according to genomic position using samtools. The rmdup function from samtools was used to
remove potential PCR duplicates. The processed *.bam files were further analyzed using R
package DESeq2(228). A FDR corrected p-value cut-off of 0.1 was used to call differentially
expressed genes. Correlation and overlaps were performed in R (R> 3.0.0).
DNA digestion with PvuRst1L and DNA sequencing: PvuRts1I (Pvu) restriction enzyme can directly
cleave hydroxymethylated DNA 12-14 bps away from the 5hmC site(229). We developed a new
technique that we call Pvu-seq which allows direct detection of 5hmC without chemical
modification of 5hmC or bisulfite conversion. A paper describing this technique was published in
BMC Genomics (230). Briefly, the whole genomic DNA extracted from dTet KD, Mt2 KD and
w1118 pupae, was digested with PvuRts1I and sequenced using 50 bps paired end sequencing
reads in Illumina™ HiSeq 2500.
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Statistical analysis for Pvu-Seq data: Pvu-Seq was used to confirm the presence of 5hmC in the
predicted Pb-dependent high density 5hmC clusters (230). *.Fastq files for Pvu-Seq was aligned
to the dm3 (UCSC) reference genome build using bowtie2. The *.sam files were converted to
*.bam files and sorted according to genomic position using samtools. rmdup function from
samtools was used to remove potential PCR duplicates. The data was further filtered using a
mappability score cut-off of 10 and only reads with mapped mate pairs was used for downstream
analysis. The differential coverage between w1118 and dTet was calculated using R package
MEDIPS within 200bps genomic windows (R> 3.0.0). Genome wide differential coverage between
two groups of samples where modelled as a negative binomial distribution. For this, MEDIPS
applies edgeR(231) and its functions for normalization, estimation of over dispersion, and
statistical testing. The log2 fold change is coverage was estimated as log2 (Experiment/w1118,
control). DhMs were called for all peaks with FDR corrected p-value ≤ 0.1. Adjacent windows
were merged together to form larger windows to reduce the number of regions. Reads per kilo
base per million reads (rpkm) values were processed *.bam files and outputted as *.wig files for
visualization in Integrative genome viewer. Distance of the peaks from the nearest 5’ end of
genes, and the distance from the gene were calculated using annotatePeak function from R
package ChIPSeeker, using TxDb.Dmelanogaster.UCSC.dm3.ensGene as the reference database.
Correlation and overlaps were performed in R (R> 3.0.0).
Motif Discovery: For discovery of the consensus sequences for dTET enzymatic activity, we
selected all unmerged significant DhMs and did a de-novo motif discovery using motifRG package
in R (R> 3.0.0) (232). We used the dm3 genome build tile into 200 bps regions as the background
sequence to estimate the seed motif, and search for the enrichment of seed motif in DhMs. The
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top 5 motifs are reported in the paper. For determination of known transcription factor binding
motifs in DhMs located in the Promoter regions of the differentially expressed genes we used
PWMEnrich package in R (R> 3.0.0) and search for significant enrichment against a database of
known transcription factor binding motifs, which can found in Bioconductor database
PWMEnrich.Dmelanogaster.background in R (R> 3.0.0).
4. Results
4.1

Sequence comparison of TET homologs
While mammals possess three types of TET protein, TET1, TET2 and TET3, Drosophila has

only one TET homolog, CG2083 (CG43444), which we renamed dTET. The dTET gene is located on
chromosome 3L, is 92kb long and has 12 exons (233). The translated product of dTET (isoform F)
contains 2921 amino acids. To determine the possible function of the dTET, we first compared

Figure 20: Comparison of the similarity of predicted protein secondary structure of dTET and
its homologs from different species using ScanPosite analysis. The comparison sequences
include TET1_human, TET1_Mouse, TET2_Human, TET3_Mouse, TET2_Human,
TET2_Mouse, LOC580376_Sea Urchin, CG2083_Drosophila, V1g22996_nematostella,
gp2_mycobacterium phage cooper, FRAAL2749_Frankia alni, JBP1_Trypanosoma Brucei,
JBP2_Trypanosoma Brucei, CC1G_03999_Coprinopsis, LACBIDRAFT_316849_Laccaria,
P4H_Chlamydomonas (PDB:2JIJ), ALKB_Ecoli (PDB:2FD8).
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the predicted amino acid sequence of dTET with its homologs in different species (Figure 21).
ScanPosite analysis showed that dTET contained a Zinc Finger CXXC structure from AA647 to
AA687. There were two Tet/JBP family signature domains, between sequences AA1857 -AA2091
and AA2527-AA2727, which consisted of a double-stranded beta helix (DSBH) fold domain
belonging to the 2-oxogluatarate (2OG)-Fe (II)-dependent dioxygenase (2OGFeDO) superfamily.
All three mammalian TET members possess the DSBH domain, and this

is essential for the

binding of metal ions that catalyze the oxygenase function (234).
The CXXC domain is only possessed by TET1/3 and is required for the binding to
chromatin. However, the mammalian TET2 lacks the CXXC domain and needs the assistance of
another protein, IDAX, (possible Drosophila homolog: CG9973) for binding (235). The analysis of
multiple sequence alignment through Blast protein indicated that dTET shared a similar Zinc
Finger CXXC domain, Tet/JBP family-specific structure, and the amphipathic helix pattern with
TET1 and TET3 in human and mouse, as well as orthologs in Sea urchin and Nematostella. The
similarity extended into the DSBH-2OG-Fe (II)-dependent dioxygenase domains, shared by the
characteristic residues and beta strand.
It is clear that the dTET possessed all structural elements and catalytic residues
characteristic of the TET/JBP superfamily: Histidine and Aspartic acid, a small amino acid in the
strand after the N-terminal Helix and the Histidine, the small amino acid, Arginine and the
aromatic amino acid in the stands close to the C-terminal. But it is worth noticing that dTET
shares more similarity with TET1 and TET3 than mammalian TET2 because TET2 lacks the Zinc
Finger CXXC domain. As mentioned above, since dTET possesses the catalytic domain of DSBH
and the chromatin binding domain of CXXC Zinc Finger, it is possible dTET can directly interact
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with chromatin.
4.2

dTET is Required for Optimal Transcription and Hydroxymethylation of the Nuclear and

Mitochondrial Genome
Our investigation on the role of dTET has been carried on a loss-of–function dTET
mutation strain, the pupal-lethal dTETEP/EP, which has a homozygous PiggyBack insertion between
exon 6 and 7. The allele information was shown in Table 2. Next, we compared the dTET mRNA
level in control Drosophila (w1118) and dTET mutants using an RNA sequencing technique. The
data showed that the dTET mRNA level in dTETEP/EP was significantly reduced compared to w1118
Drosophila (Figure 22, a and b), which indicates successful dTET KD in dTETEP/EP strains at the
transcription level. Next we explored how the reduction of dTET protein would affect the genome
hydroxymethylation level in Drosophila.
We used Pvu-sequencing to identify hydroxymethylation sites in both w1118 and
dTETEP/EP pupae. Pvu-sequencing is a new technique developed in the Ruden laboratory by
digesting the purified genomic DNA sample with PvuRts1I, which is a Type 2 restriction
endonuclease that recognizes single 5-hmC sites within CGAT/CG sequences and generates
fragments with 3’-cohesive termini, followed by next-generation DNA sequencing (236). Since
the distances between the cleavage sites and 5-hmC sites are often 11-13 nucleotides in the top
strand and 9-10 nucleotides in the bottom strand(237), Pvu-seq could be an ideal method to
detect the density and distribution of 5-hmC in the genome and also the relative genomic 5- hmC
levels in particular regions. As expected, we observed about a 50% reduction of 5-hmC levels in
dTETEP/EP mutant Drosophila while the distribution pattern of 5-hmC was similar between mutant
and control Drosophila (Figure 22, c and d). We also noticed that long intron in which EP995
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resides is poorly spliced in the KD pupae. It shows the insertion mutation of the EP995
transposon between exons 6 and 7 in the dTET gene (Figure 22, e). The results confirmed that
dTET was KD at the transcription level and was directly associated with generation 5-hmC in
Drosophila.
In addition to the nuclear 5-hmC level reduction, we also observed that the global
hydroxymethylation level in dTETEP/EP Drosophila was significantly reduced compared to control
Drosophila (Figure 235, dTET gene as example). This shows the importance of dTET in the process
of maintaining DNA hydroxymethylation level in Drosophila. We also observed substantially
reduced hydroxymethylation in mitochondrial genes, such as Co1, CoII, and ATPase6, etc. (Figure
23 b). It is worth noting that the hydroxymethylation regions on the 19kb mitochondrial genome
were nearly eliminated. Thus, the deficiency of dTET caused greater 5-hmC reduction in
mitochondrial DNA than in the nuclear DNA in dTETEP/EP Drosophila and control.

Figure 21: The global hydroxymethylation level in dTETEP/EP Drosophila was significantly
reduced compared to WT Drosophila. (a) 5-hmC and oxidative modification marker results of WT
and dTETEP/EP at the dTET site. (b) 5-hmC and oxidative modification marker results of WT and
dTETEP/EP at mitochondrial DNA. Both results showed a reduction of 5-hmC in dTETEP/EP strains
and the sites are similar to the distribution of oxidative modification markers.
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Genotype

Phenotype

dTETRev-1 / T-L

Precise Excision of EP; adults survive

OgaP / OgaP

Adults survive; partial male sterile

dTETEP / T-R

Adults survive; weak climber

dTETEP OgaP / T-R

Adults survive; weak climber

T-L / T-R

Some adults survive; weaker climber

dTETEP / T-L

Black pupal lethal

dTETEP OgaP / dTETEP OgaP

Black pupal lethal

dTETEP OgaP / T-L

Black pupal lethal

dTETEP / dTETEP

White pupal lethal

Table 2. Allelic Series of dTET and Oga single and double mutant phenotypes. The weakest
phenotype is on the top, and the most severe phenotype is on the bottom.
4.3

dTET is Required to Oxidatively Modify the Mitochondrial Genome
Recent discoveries revealed that TET proteins may have participated in the oxidation of 5-

mC

into 5-hmc, 5-fC, and 5-caC followed by the BER DNA repair pathway. It is possible that oxidative

damage could have occurred at a higher rate near hydroxymethylation sites. After confirming the
role of dTET in global hydroxymethylation, we conducted a series of assays to measure different
types of DNA oxidative damage in control and dTETEP/EP Drosophila. The experiment was
performed by treating control and dTETEP/EP Drosophila DNA with five different DNA oxidation
damage specific glycosylases followed by next-generation DNA sequencing to reveal the
distribution of oxidative damage (Figure 23 and Table 5). The glycosylases we tested includes 2-
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Methyladenine DNA Glycosylase Type II (AAG), which initiated base excision repair (BER) when
certain substrate bases were recognized such as

3-methyladenine, 3-methylguanine, and 7-

methylguanine, etc., after DNA damage; Concanavalin A (ConA) is a lectin (carbohydrate-binding
protein) which specifically interacts with glycoprotein and glycolipids; Human 8-Oxoguanine
glycosylase 1(hOGG1) recognizes and remove the DNA damage product 7,8-dihydro-8 oxo
guanine (8-oxoG) and 2,6-diamino-4-hydroxy-5-fromamidopyrimidine (FaPy); Thymine glycol
DNA glycosylase (TGDG) removes DNA bases damaged by UV light and produces a single
nucleotide gap, Uracil-DNA glycosylase (UNGase) eliminates uracil produced from cytosine
deamination through BER pathways.
According to the results, we found that like 5-hmC, the distribution of oxidative-damaged
DNA nucleotides are enriched in the promoter regions (Figure 23 a). Surprisingly, in the
mitochondria, the levels of DNA oxidative damages in the promoter regions of mitochondrial
genes are significantly reduced in dTETEP/EP Drosophila compared to control Drosophila (Figure 23
b). The relatively greater abundance of ConA in both control and dTETEP/EP, in both nuclei and
mitochondria, is different compared to other oxidative damage markers. We conclude that 5-hmC
oxidative modifications to DNA correspond to several other types of oxidative changes to DNA.
This suggests that dTET, like the BER enzymes, is a DNA repair enzyme that is involved in
removing 5-mC from the genome.
4.4

dTET Mutations Enhance the Extra-Sex Combs Phenotype of PcG Mutations.
The Polycomb Group (PcG) is a protein family which regulates gene silencing through

epigenetic chromatin remodeling and plays important roles in development (238). Conversely,
the Trithorax Group (TrxG) proteins antagonize the effects of PcG proteins by maintaining an
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activated status of target genes. An additional copy of the TRXG gene kismet (kis) was used in the
genetic assay to screen for suppressor of Polycomb (Pc) activity because the insertion of an
added copy of TrxG gene kismet sensitizes the genetic background and enhances the penetrance
of the extra-sex-comb phenotype of PcG loss-of-function mutations.
In heterozygous TET mutant dTETEP/TM6 male adult Drosophila, we observed an
enhancement of the extra sex combs phenotype, which is the unique property of PcG mutations:
the ectopic sex combs are on 2nd and 3rd pair of legs instead of only the first pair (Figure 24 a, E-

Figure 22: Extra sex combs in heterozygous TET mutant dTET EP/TM6 male adult
Drosophila. (A) Cross scheme of extra sex comb assay. The duplication of kismet
sensitizes the genetic background for the phenotype penetrance. (B) The cross scheme
of introducing PcG mutation showed extra sex comb on the second and third legs. (C)
The introducing of TrxG mutation showed limited extra sex comb on the second and
third legs. (D) The introduction of an additional copy of PcG gene increased an extra sex
comb number on second and third legs. (E-G) Microscope Images of sex combs on 1st.
2nd, and 3rd legs of dTETEP/TM6 males.
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G).This indicates that dTET belongs to the PcG family. To confirm this finding, we introduced
series of mutant PcG alleles into dTETEP/TM6 Drosophila (Table and Table 1). As we expected,
the additional sex comb number was further increased due to the enhancement from the
mutant PcG alleles. On the other hand, when a mutated O-GlcNAcase (Oga) allele was introduced,
which is a TrxG member; the number of extra-sex combs on the 2nd and 3rd pairs of legs was
suppressed. This suggests that Oga and dTET genetically interact. The TrxG property of Oga
counteracted with dTET mutation and reduced the extra sex combs.
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Genotype

Leg1

T124; Pc4 pp/TM3,Sb

Leg2
1

Leg3
5

2

Reference

0

0

Scr is in TrxG

1

0

Oga suppresses

0.19
T124; Scr17/ Pc4

.62
5

.75
T124; OgaP,
dTETEP/Pc4

.75
9

.85

T124; OgaP / Pc4

.3
1

0.33
T124; dTETEP / Pc4

.33

1.05

.125

0.75

.9

.8
T124; Scm01/ Pc4
0.88

.15

dTET is in PcG

4

sxc is in PcG

7

Df(3L)(T-R) is in
PcG

7

Pcl is in PcG

9

Scm is in PcG

.95
1

0.5

5

.3
9

1

on Pc

.44
7

9

Oga has no effect

.7
6

1

T124; PCL11/ Pc4

.18

.3

0.4

dTET
2

8

1

T124; T-R/ Pc4

.5
4

1

T124; sxc6/ Pc4

Comments

.25

Table 1: Mutations in dTET enhance the Pc4 ectopic sex comb phenotype.
4.5

The ELBO Assay Indicates that dTET is in the PcG

84
We further deployed another well-established model, the Ectopic Large Bristle
Outgrowths (ELBO) phenotype, which was developed in the Ruden laboratory in 2003 (Sollars et
al.), to assess whether dTET belongs to the PcG family (). The Kruppel (Kr) gene encodes a
transcriptional factor that maintain the development of thoracic and abdominal sections(239). Its
dominant allele KrIrregular facet, also called KrIf-1, showed a sensitized background responding to the
mutation of TrxG or PcG genes. The inheritable epiallele could be induced by TrxG mutation and
suppressed by PcG mutation, which exhibit the ectopic expression of Kr proteins in the ventral
region of eye imaginal disc. This ectopic expression not only results in the crude appendage-like
structure protruding from ventral regions but also reduced the size of eyes (240). As we
expected, the presence of a dTETEP reduced the rate of ELBO formation from 60-70% to below
10% while the KrIf-1 heterozygous Drosophila only show less than 1% ELBO progeny in the
presence of the dTET mutation. The introduction of ELBO enhancer and suppressor alleles
increases or decreases the rates of ELBO phenotype, individually (Table 4, Figure 25 C and D). All
of the results confirm that dTET belongs to PcG family.
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Mother’s Genotype

Father’s

F1 Genotype

% ELBOs (total)

Comments

Genotype
KrIf-1/ KrIf-1

w1118

KrIf-1 / w1118

0% (533)

Negative control

KrIf-1*/ KrIf-1*

w1118

KrIf-1* / w1118

67% (551)

Positive control

Scr17 / Bal

KrIf-1*/ KrIf-1*

KrIf-1*/+; Scr17/+

95% (508)

Scr is in the TrxG

Scr17 / Bal

KrIf-1*/ KrIf-1*

KrIf-1*/+; Bal/+

64% (555)

Scr has no ME

OgaP / Bal

KrIf-1*/ KrIf-1*

KrIf-1*/+; OgaP /+

94% (568)

OgaP is in the TrxG

OgaP / Bal

KrIf-1*/ KrIf-1*

KrIf-1*/+; Bal/+

62% (531)

OgaP has no ME

dTETEP/Bal

KrIf-1*/ KrIf-1*

KrIf-1*/+; dTETEP /+

5% (539)

dTET is in the PcG

dTETEP /Bal

KrIf-1*/ KrIf-1*

KrIf-1*/+; Bal/+

69% (500)

dTET has no ME

Pc4 / Bal

KrIf-1*/ KrIf-1*

KrIf-1*/+; dTETEP /+

7% (598)

Pc4 is in the PcG

Pc4 / Bal

KrIf-1*/ KrIf-1*

KrIf-1*/+; Bal/+

62% (583)

Pc4 has no ME

dTETEP OgaP / Bal

KrIf-1*/ KrIf-1*

KrIf-1*/+; dTETEP

9% (587)

Oga suppresses

OgaP /+
dTETEP OgaP /Bal

KrIf-1*/ KrIf-1*

KrIf-1*/+; Bal/+

dTET
69% (542)

Oga and dTET have
no ME

Table 4. Mutations in dTET suppress the Ectopic Large Bristle (ELBO) Phenotype.

86

Figure 23: Ectopic Large Bristle Outgrowths (ELBO) phenotype, to assess whether dTET
belongs to the PcG family. (A) The negative control cross plan showed maternal Kr [If-1] and
WT had normal progeny. (B) The positive control cross plan showed Kr [If-1]* induces
increased ELBO in progeny. (C) The introducing of TrxG gene showed more ELBO progeny.
(D) The introduction of the extra copy of PcG gene showed reduced ELBO progeny. The
electronic microscope results showed that compared with (E) WT, the Kr [If-1] mutant (F)
showed irregularly formed and smaller eyes. (G-H) Microscope Images of bristle-like
appendage structure (*).
4.6

The Genes Near the Chromosome 3L Telomere Require dTET for mRNA expression
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Another interesting finding is that besides mitochondrial DNA, the telomere region near

NGS Technique
Pvu-seq

Method
Digest DNA with PvuRts1l (Active Motif)

Results
Maps 5hmC sites
(Ruden et al., 2013; in press)

AAG-seq

Digest DNA with mouse 3-methyladenine
DNA glycosylase type II (Aag protein,

Maps 3-methyl adenine (3mA)
(This grant)

Trevigen)
ConA-seq

OGG1-seq

TGDG-seq

Purify sonicated DNA with concanavalin A

Maps glycosylated sites in DNA (glcDNA)

lectin (ConA protein, Sigma)

(This grant)

Digest DNA with human 8-oxoguanine DNA

Maps 8-oxoguanine sites in DNA (8oxoG)

glycosylase (hOGG1 protein, Trevigen)

(This grant)

Digest DNA with thymine glycol-DNA

Maps thymine glycol sites in DNA

glycosylase (E. coli Endonuclease III,

(This grant)

Trevigen)
UNG-seq

Digest DNA with Uracil-N-

Maps uracil sites in DNA

glycosylase (E. coli UNGase, Trevigen)

grant)

(This

Table 5. Next-generation sequencing (NGS) techniques developed by the Ruden laboratory
to map oxidized DNA. To detect 5mC DNA in mtDNA, we will use the enzyme MbrBC,
which cleaves 5mC DNA (1, 2)
chromosome 3L (from 0 kb to 140 kb) was also significantly hypo-hydroxyl methylated in
dTETEP/EP pupae. Also, the mRNA transcription level of the genes in the 3L region was significantly
reduced in dTETEP/EP pupae. As shown here, the Pvu-sequencing res7ults show that the 5-hmC
level near mth18 gene promoter region and within the gene body, which is within the first 140 kb
of chromosome 3K, was diminished to an undetectable level (Figure 26 A). The RNA-Seq results
showed that the mRNA level of mth18 is also brought down to less than 1% compared to control.
We also examined the other genes within the 140k region of 3L telomere locus in dTETEP/EP pupae,
including CG43149, Lsp1gamma, and Pdk1. All of the genes showed a reduction in the 5-hmc level
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Figure 24: The Pvu-seq and RNA seq results compare dTET mutant (dTET-) and WT (dTET+)
Drosophila. (A) Pvu-Seq and RNA-Seq showed dTET mutant had lower 5-hmC level and mRNA
transcription near 3L telomere region at mth18 gene promoter sites and within the gene. (B)
CG43149 and Lsp1gamma showed both lower 5-hmC and transcription level. (C), Pdk1 also
showed lower 5-hmC and transcription level, indicating reduced hydroxymethylation and
transcription in 3L telomere regions.
and transcription levels (Figure 26 B and C). The Pdk1 gene, which was located furthest from the
telomere region, shows a relatively moderate reduction in both 5-hmC and transcription. The
difference between Pdk1 and other tested genes may be due to the distance from the 3L
telomere. Since we do not observe the similar pattern in other telomere regions, it is possible
that the 3L telomere region may contain certain chromatin structures with unique properties
that affect hydroxymethylation and transcription activity. In summary, the genes within
chromosome 3L telomere region show hypo-hydroxymethylation and limited transcription
activity similar to mitochondrial genes. To our knowledge, this is a unique observation for which
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Figure 25: Protocol for glycosylase-seq experiments to analyze DNA damage in mtDNA and
ncDNA. (a), Oxidized mtDNA and ncDNA is digested with a DNA repair glycosylase, which
generates abasic sites in the DNA. hAPE1 (Sigma, Inc.) cleaves the DNA at the abasic sites, and
the DNA is purified on an agarose gel. The next-generation sequencing (NGS) library is made
with the short dsDNA with the Rubicon ThruPlex™ FD Prep Kit that requires only 5-10 ng of
DNA. b, Agarose gene showing Drosophila pupae DNA digested with the indicated
glycosylases and hAPE1 (this grant).
we have no explanation. Furthermore, we also looked at the distribution pattern of oxidative
damage markers within the Chromosome 3L telomere regions. As we expected, control
Drosophila show peaks of all six oxidative damage markers co-localized with 5-hmC peaks (Figure
27 and Figure 28), indicating possible oxidative damage sites coincide with hydroxymethylation
locus. The dTETEP/EP Drosophila, however, have less oxidative damage in the 3L region. This
phenomenon is much like the results in the mitochondrial genome. We also notice that when
located further from the 3L telomere region, the CG13405 and CG12483 shows less reduction in
hydroxymethylation level in dTETEP/EP Drosophila (Figure 28 C).
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Figure 26: WT and dTET Drosophila show peaks of all six oxidative damage markers colocalized with 5-hmC peaks in 3L telomere region. WT and dTET Drosophila show peaks
of all six oxidative damage markers co-localized with 5-hmC peaks in 3L telomere region.
(A) Pvu-seq and showed dTET mutant had lower 5-hmC level, and the distribution
pattern is similar to oxidative modification marker at mth18 locus near 3L telomere
region. (B) CG43149 and Lsp1gamma both showed lower 5-hmC level in dTET mutant
which co-localized with oxidative modification markers. (C) Pdk1 also showed lower 5hmC in dTET mutant and a similar pattern as oxidative modification markers
5. Discussion
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The Drosophila model has been deemed as one of the most powerful models in
epigenetics research. However, the existence of DNA modification in Drosophila is still
controversial despite the detection of a trace amount of 5-mC in Drosophila by Achwal and
colleagues in 1983 (241). The missing of 5-mC from Drosophila genome raises the important
question whether the DNA modification, including methylation and hydroxymethylation is
essential for eukaryote cell development. It is well accepted that 5-mC does not exist in the
Drosophila genome until the identification of Dnmt2 homolog in Drosophila in 1999(242). The
presence of 5-mC was exploited and quantified by Gowher and colleagues at 2000 using
methylation dependent restrictive enzyme McrBC analysis and HPLC. They quantified the
percentage of 5-mC to be 1 in 1000 to 2000 cytosines(243). Further research revealed more
detailed information about the function and dynamic regulation of DNA methylation. The
expanding investigation has advanced in recent years, especially after the significant progress
towards the 5-hmC function and the methylation dioxygenase TET family proteins (201, 204).
The role of TET in converting 5-mC to 5-hmC, and to further products such as 5-fC and 5caC, provides us with possible answers to a long-lasting question of how the 5-mC is dynamically
regulated and removed from the genome at certain development stages. But, when extensive
studies had been conducted in mammalian models, ours is the first study of the 5-hmc distribution
and function in Drosophila models. Currently, there is no publication about the characterization
of Drosophila TET homolog, dTET, nor the systematic analysis of its function. Our lab’s previous
study showed enriched non-CG hydroxymethylation in introns of honey bees (Apis Mellifera)
using a highly sensitive whole-genome shotgun Pvu bisulfite sequencing method (244). To
further characterize the properties and functions of TET, we extended the study to the field of
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Drosophila.
The bioinformatics analysis shows that the Drosophila TET homolog CG2083 shares
structural similarities with mammalian TET 1/3.

The C-terminal conserved CXXC domain and

Tet/ JBP family specific domain indicate that dTET is capable of binding chromatin independently
without the assistance of partner proteins such as IDAX in mammalian cells. We obtained dTET
mutant strain by inserting EP995 transposon into the dTET gene, resulting in a pupal lethal
dTETEP/EP strain with more than 90% dTET mRNA reduction in the early pupal stage. Our findings
from the Pvu-sequencing of dTETEP/EP confirm over 50% reduction of global 5-hmC level. In
previous study of mouse embryonic stem cell, the TET1 depletion causes about 40% loss of 5-hmC
level, which is similar to our results and confirms the essential role of dTET in hydroxymethylation
process(207).
An unexpected finding is that we observed that the mitochondrial 5-hmC level was nearly
diminished compared to the control. At the same time, the mRNA levels of several mitochondrial
genes like Co1, CoII, and ATPase 6 are significantly reduced in dTETEP/EP Drosophila, together with
3 fold reduction of hydroxymethylation level in the gene body. This is the first time that a
significant impact of TET protein decrease in the mitochondrial gene transcription and
hydroxymethylation levels were reported. The reduction of gene transcriptions matches the role
of 5-hmC in facilitating gene activation from previous research. Currently, there are very few
studies on the mitochondrial DNA epigenetic modifications. In 1973, Nass showed that mtDNA in
mouse, hamster, and hamster cells are hypomethylated compared to ncDNA(245). The existence
of mtDNA methylation and hydroxymethylation were confirmed in mammalian cells again in
2011 by Shock et.al(246). They proposed that a special mtDNMT1 protein, which carries a
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mitochondrial targeting sequence, translocated to mitochondria and processed the mtDNA
methylation. Our finding suggests that dTET is essential for both the mitochondrial gene
transcription and mtDNA hydroxymethylation. Currently, we have not identified how the dTET is
associated with the reduction of mitochondrial DNA transcription, nor the causal relationship
between the reduction of transcription and 5-hmC level in mitochondrial. There may be possible
interactions between dTET and the critical mitochondrial transcriptional factors such as POLRMT
(mitochondrial RNA polymerase), TFAM (mitochondrial Transcription Factor A), or TFB2M
(mitochondrial Transcription Factor B), which will be further tested (247, 248).
While some genes’ transcription in dTETEP/EP show reduction compared to control, we
observed a group of genes showing upregulation the mutant strains. Among the 200 most upregulated genes are a group of 21 Cytochrome P450 (CPR) genes, including the top three: Cpr30B
(up 13.39 folds), Cpr30F (up 12.13 folds), and Cpr76Bb (up 11.75 folds). CPR genes are required
for the electron transfer and function of cytochrome P450 in the endoplasmic reticulum
(ER)(249). It is not clear about the function of Cpr30B/30F/76Bb or the association with dTET
reduction, but it may reflect a particular ER feedback to encounter the mitochondrial
malfunction. The changes in dTETEP/EP strains were not only in the expression level of the gene
but also the transcription pattern. We observed that the transcription direction of CG34199 gene
was reversed in TET mutant Drosophila compared to control Drosophila. The Cpr56F gene in
dTETEP/EP, which is a skipped intron in the CG34199 transcription in control Drosophila, was
transcribed instead. This phenomenon hasn’t been reported before and may be associated with
the different expression patterns in control and mutant Drosophila.
Another interesting finding is that although the Drosophila global genomic
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hydroxymethylation is affected by the absence of dTET, most of the ncDNA regions still have
measurable amounts of 5-hmC left. The only exception is the chromosome 3L region, expanding
about 140 kb from the 3L telomere, with almost undetectable 5-hmC levels. Currently, it is not
clear why the 3L telomere region has such significant reductions because the other telomere
regions show average levels of 5-hmC. A Study reported that 3L distal region has a lower-thanaverage gene density, which includes a dominant Polycomb group suppressor gene, lethal 1, and
a lethal 3 gene which corresponds to a trithorax group gene verthandi (vtd)(250). The reduction
of 5-hmC may not be related to the formation of heterochromatin because previous studies show
that the heterochromatin structure in chromosome 3L is genetically similar to chromosome
2L(251). The study from Zhang et.al shows Tet catalyzing active DNA demethylation mainly in
distally located enhancers in mouse ESCs (252). They also observed Tet KD Escs have increased
telomere-sister chromatid exchanging rates, indicating Tet may be related telomere homeostasis.
The similarity of chromosome 3L and mtDNA in hydroxymethylcytosine distribution pattern and
the aforementioned BER pathway enzymes will be further investigated.
Previously studies hypothesized that TDG activation and BER pathways may be
downstream of the hydroxymethylation process to demethylate actively 5-mC into cytosine.
Muller et.al demonstrated that purified TET1 catalytic domain could reactivate the genes
silenced by methylation. Interestingly, the reactivation requires the participation of a group of
BER glycosylases such as TGD, PARP1, XRCC1, and LIG3(253). Sun and colleagues reported that
when overexpressing TDG in Germinal Vesicle (GV) stage mouse oocyte, they observed
decreased genomic 5-mC, as well as decondensed chromatin (28). We tested five different types
of DNA oxidation residues, such as AAG and ConA, using specific antibodies immunoprecipitation
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followed by sequencing. We found their distribution patterns are similar to the 5-hmC pattern,
and all the oxidation nucleotides are enriched in promoter regions. The most similar pattern
comes from ConA, which resembles most of the peaks from 5-hmC in control Drosophila and
dTETEP/EP Drosophila. We also observed the same similarity in Drosophila mitochondrial. This
result supports the theory that dTET oxidizes DNA in the nuclear genes promoter region, and the
product, such as 5-fC and 5-caC, might be recognized by Glycosylase members from BER
pathways and restored to unmodified cytosine.
Since the OGT protein, which glycosylates histones, is encoded by a PcG gene Super Sex
Comb (sxc) in Drosophila, we tested if dTET also belongs to the Polycomb Group. The testing of
Sex Comb Model shows that when the T(2, Y) kismet allele sensitizing the multi-sex comb
phenotype, the introducing of dTET allele increased extra sex combs on first pair of legs, and
developed ectopic sex combs on the second and third pair of legs, which showed that dTET is a
polycomb group protein. The ELBO model results also confirmed it. While the previous studies
revealing that the connection between TET and PcG protein OGT in mouse ESCs, our findings
provide evidence that these two PcG proteins could coordinate for a novel demethylation
pathway by iteratively oxidizing 5-mC(254). It is worth noticing that the OGA protein, which
counteracts the OGT activity by catalyzing the reverse reaction of 5-hmC oxidation, is a TrxG
protein. The antagonism of OGA and OGT in oxidizing 5-hmC could perfectly fit into the
counteraction of PcG and TrxG members.
The model for How dTET Regulates Expression of the Mitochondrial Genome
Recently, Forneris et al. proposed that the lysine specific demethylase 1 (LSD1) could play
a major role in de novo DNA methylation and formation of heterochromatin (255). It reported
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that LSD1 not only act as a transcriptional co-repressor, but may also activate transcription by
colocalize with RNA Pol II on many target gene’s promoters(256). The crystallography results
showed that LSD1 share 20% sequential similarity with flavin-dependent monoamine and
polyamine oxidase (MAOs and PAOs) and are possible to act as amine oxidase under certain
circumstances. It is very interesting that research shows the demethylation ability of LSD1 is not
limited in Histone 3 lysine 4 tails. Reports revealed that LSD1 could also demethylate Histone 3
lysine 9 without change the methylation status of H3K4, which indicate the possibility of LSD1 to
demethylate other Histone residues (257). More importantly, unlike the other jumonji family
histone demethylases, LSD1 could produce H2O2 during the demethylation process, which acts as
a signaling molecule for multiple pathways (258). And Perillo et al. reported that the DNA
oxidation could also be promoted by the estrogen treatment induced H3K4/H3K9 demethylation
process by LSD1, during which the produced H2O2 causes oxidative damages and recruited the 8oxoguanine-DNA glycosylase 1 to modify DNA bases. (259). This observation could be further
extended to explain the trigger for the demethylation process of 5-mC to 5-hmC in dTET nuclear
and mitochondrial DNA. Based on the above results and previous studies, we propose a model
that, under normal circumstances, the histones surrounding nuclear DNA were demethylated by
Jumonji family proteins such as LSD1 or KDM2. The demethylation produced hydrogen peroxide,
which may trigger hydroxymethylation by TET and/or recruits glycosylase to the nuclear DNA for
oxidative damage modification, and turns on the gene transcription by Pol II. (Figure 29 A).In
control mitochondria, although no histone and histone demethylase presents, dTET protein
alone could still demethylate the 5-mC and producing hydrogen peroxide to modify the bases and
activate transcription. (Figure 29B). In contrast, the dTET mutant Drosophila lack the dTET protein,
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but the nuclear histone and DNA can still be demethylated by LSD1. The 5-hmC can be removed by
oxidation modification caused by glycosylase for DNA modification while maintaining the
transcription level (Figure 29 C). So this could explain the relatively unchanged transcription
activity in ncDNA between control and dTET mutants. But in dTET mutant mitochondria, because
there are no histone demethylases available, the methylation level remains constant, and no
hydrogen peroxide is produced to modify mtDNA. The transcription level remains low compared
to control (Figure 29 D).
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Figure 27: The Hypothetical model for dTET function. (A) Under normal conditions, the histones
surrounding nuclear DNA are demethylated by Jumonji family proteins such as LSD1. The
demethylation reaction by dTET produces formaldehyde which may modify the DNA and
increase transcription by Pol II. (B) In WT mitochondria, where there are no histones on mtDNA,
TET alone demethylates the 5-mC and produces formaldehyde which modifies the bases and
activate transcription. (C) In dTET mutant Drosophila, the nuclear histones and DNA can still be
demethylated and by Jumonji proteins and oxidize the DNA. (D) In dTET mutant mitochondria,
because there are no histone demethylases available, and no formaldehyde is produced to
modify mtDNA. Therefore, the transcription levels of mitochondrial genes remain low.
According to the previous research showing that TET is interacting with OGT, we
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constructed a series of dTET and Oga single and/or double-mutant to examine the outcome of
mutation (Table 2). Here we found that dTET double mutant dTETEP/EP showed the severe
developmental arrest and caused white pupal lethal, indicating the importance of dTET in
development.

While the dTETEP/T-L with deleted dTET catalytic domain was black pupal lethal,

dTETEP/T-R, which has deleted 5’ part of dTET gene but still contain the catalytic domain, shows
only reduction of climbing ability, implying the dysfunction induced by limited dTET activity. In
comparison, the homologous Oga mutant OgaP/OgaP showed relatively unchanged survival rates
but a fraction of the male adults were sterile, indicating possible alternative pathways to
substitute Oga functions. Interestingly, the dTET and Oga double knockout dTETEP OgaP / dTETEP
OgaP showed black pupal lethal, which is less severe than dTET mutation.
Currently, it is not clear why the Oga mutant delays the developmental arrest in dTET
mutation. The dTETEP OgaP / T-R line contains one copy of Oga and one copy of dTET catalytic
domain, showing declined locomotor ability but with normal viability. In contrast, the dTETEP
OgaP / T-L lost both copies of dTET catalytic domains, showing interrupted development during
the black pupal stage. Taking together, the increasing survival rates of adults among dTETEP /
dTETEP, dTETEP / T-L, and dTETEP / T-R showed that one copy of 5’ end dTET with no catalytic
domain could delay the development stoppage a copy of 3’ end dTET with catalytic domain could
support partial adult survival but with reduced locomotor activity. But it is currently unknown
why the dTETEP / T-R showed better survival than T-L / T-R. When the Oga mutant was introduced
into dTET mutation background, we found that even with both copies of Oga deleted, the
phenotype of progeny of dTETEP OgaP / dTETEP OgaP did not worsen compared to dTETEP / dTETEP
single knockout. And the comparison between dTETEP / T-R vs. dTETEP OgaP / T-R, and dTETEP / T-L
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vs. dTETEP OgaP / T-L, showed that the absent of one copy of Oga on the background of TET
heterozygous mutation background does not cause significant changes.
In conclusion, our work characterized and confirmed the vital role of TET function in DNA
hydroxymethylation and demethylation, as those findings in other eukaryotes and mammalian
organisms. By RNA-seq, we showed a reduction of dTET mRNA levels in dTET-mutant Drosophila.
Pvu-seq demonstrates that the 5-hmc levels in nuclear and mitochondrial DNA were both
significantly reduced, which confirms the role of dTET in the conversion of 5mc to 5hmc

both

nuclear and mitochondrial DNA. Finally, we propose a model that, under normal circumstances,
dTET and Jumonji proteins bind to the promoter regions of target genes. In the nucleus, the dTET
and the Jumonji histone demethylase families of dioxygenase proteins will produce formaldehyde
and oxidize DNA in the promoters. This will lead to increased transcription by increasing the
access to RNA polymerase. However, in mitochondria, Jumonji proteins are also absent because
there are no histones, the oxidation is only produced by dTET. This helps explain why
transcription is more dependent on dTET in the mitochondria than in the nucleus.
Ethics:
Since Drosophila is a member of the invertebrate and is used as an alternative subject in
human research, it will not be considered bio-hazardous during the study.
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Friedreich’s ataxia (FRDA) is an inherited autosomal recessive neurodegenerative disease.
It affects 1 in every 50,000 people in central Europe and North America. FRDA is caused by
deficiency of Frataxin, an essential mitochondrial iron chaperone protein, and the associated
oxidative stress damages. Autophagy, a housekeeping process responsible for the bulk
degradation and turnover of long half-life proteins and organelles, is featured by the formation
of double-membrane vacuoles and lysosomal degradation. Previous researches indicate that
Danon’s disease, the inherited neural disorder disease that shares similar symptoms with FRDA,
is due to the malfunction of autophagy. Based on this, we raise the question whether the
autophagy activity is modified and what is its role in FRDA. Study has shown that oxidative stress
may play a major role in the progression of neurodegenerative diseases by attacking the
cytoplasmic molecules and organelles, and autophagy is the major pathway in reducing oxidative
stress and removal of malfunctioned organelles. Additionally, autophagy has been closely related
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to cell apoptosis and organism remodeling. Mitochondrial Autophagy (mitophagy) is also the
major turnover pathway for damaged mitochondria. Therefore, the dysfunctional autophagy in
removing the malfunctioned mitochondria in FRDA may responsible for its pathogenesis. Since
the mechanism of autophagy in the development of FRDA is still largely unknown, a systematic
analysis of the status and function of autophagy pathway is needed.
My thesis is targeting at four goals: (1) to construct FRDA Drosophila model and
characterize autophagy expression pattern in each stage; (2) to determine the effect of
autophagy modification on the symptoms of the FRDA Drosophila; (3) to identify the potential
downstream events of autophagy; (4) to explore the possible upstream activities by examine
whether the AMPK or SAPK stress response pathway is involved in FRDA Drosophila. Our
hypothesis is the up-regulation of autophagy occurs in the early stage of FRDA and may induce
apoptosis or mitophagy. We identified that autophagy level is up-regulated in FRDA Drosophila
at both transcriptional and translational levels. Moreover, the overexpression of Frataxin also
increases autophagy activity. The comparable Atg5 mRNA level in both Frataxin deficiency and
overexpression Drosophila indicates this induction of autophagy in FRDA Drosophila is Atg5
independent. Autophagy inducer Methylene blue and rapamycin could partially prolong the
longevity and restore the fertility of FRDA Drosophila, but could not rescue the pupal lethal
phenotype. When treated with the autophagy inhibitor chloroquine, FRDA KD Drosophila
showed reduced longevity and locomotor activity, implying the beneficial effect of autophagy in
certain development stages. The FRDA KD Drosophila also showed up-regulated caspases-3 and
cytochrome C level, indicating enhanced apoptosis in cells with reduced Frataxin. We also
attempt to apply the heart pacing assay to evaluate the FRDA Drosophila cardiac function.
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Although the results are inconclusive, the heart pacing assay appears to be a valuable tool for
future research.
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